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ABSTRACT
There are four serotypes of dengue virus designated dengue 1 , 2 , 3 and 4 (D 1 , D2
D3 and D4) and epidemiological studies indicate that a severe complication of dengue
virus infection - dengue hemorrhagic fever (DHF) is more likely to occur following a
secondar infection. DHF is hypothesized to be immunologically mediated and may be
triggered by virus-specific T cells. It is also likely that dengue virus-specific cytotoxic T
lymphocytes (CTLs) are important for recovery from dengue virus infections. An analysis
of the immune response during acute illness and when the patient has recovered from the
infection (immune state) is therefore important as it will provide insights into the
immunopathological nature of the disease. This thesis initially examines the CD8+ CTL
responses in volunteers who have received live attenuated dengue vaccines and then
investigates acute and immune T cell responses in children following natural infection
'" .- -.. ...--... .
with dengue.
When this project was initiated, there was little available information on the
human CD8+ T cell responses to dengue viruses. PBMC from one donor had generated
memory CD8+CTL to the nonstructural protein NS3 of dengue virus. Memory
CD8+CTL responses were therefore analyzed to determine the diversity of the T cell
response to dengue virus and to identify immunodominant proteins using PBMC from
eight healthy adult American volunteers who had received monovalent live-attenuated
.-;
r/:
candidate vaccines of the 4 dengue serotyes. All the donors had specific T cell
proliferation to dengue virses and to other flaviviruses that we tested. CTLs were
generated from the stimulated PBMC of all donors and in the seven donors tested, dengue
virus-specific CD8+CTL activity was demonstrated. The nonstrctual proteins NS3 and
NS1.2a and the strctual protein E were recognzed by CD8+CTLs fTom six, five and
thee donors respectively. All donors recognized either NS3 or NS l.2a. In a donor who
received a dengue 4 vaccine, CTL killing was seen in bulk cultue against the
premembrane protein ( prM ). This is the fist demonstration of a CTL response against
the prM protein. The CTL responses using PBMC of two donors were serotye-specific
whereas all other donors had serotye-cross reactive responses. For one donor, CTLs
specific for E, NS1.2a and NS3 proteins were all HLA-B44 restrcted. For the three other
donors tested the potential restrcting alleles for recognition ofNS3 were HLA-B38 , A24
and/or B62 and B35.These results indicate that the CD8+CTL responses of humans after
immunzation with a single serotye of dengue virus are diverse and directed against a
varety of proteins. The nonstrctual proteins NS3 and NS 1.2a appear to be
immunodominant and should be considered when designng subunt vaccines for dengue.
Previously T cell responses had not been examined in people who have had
natual infections with dengue. The HLA diversity between North American Caucasians
and populations where dengue is a serious health problem, calls for the analysis of
immune responses in people who have been infected with natual circulating strains of
the virus. We examined the memory cytotoxic T lymphocytic (CTL) responses of
tc,
vii
peripheral blood mononuclear cells (PBMC) obtained from patients in Thailand 12
months after natual symptomatic secondar dengue infections. In all four patients
analyzed, CTLs were detected in bulk cultue PBMC agaist nonstrctual dengue
proteins. Numerous CD4+ and CD8+ CTL lines were generated from the bulk cultues of
two patients, KPP94-037 and KPP94-024, which were specific for the NS 1.2a and NS3
proteins respectively. All CTL lines derived from both patients were crossreactive with
other serotyes of dengue virus. The CD8+ NS 1.2a specific lines from patient KPP94-037
were HLA-B57 restrcted and the CD8+ NS3 specific lines from patient KPP94-024 were
HLA-B7 restrcted. The CD4+ CTL lines from patient KPP94-037 were HLA-DR7
restrcted. A majority of the CD8+ CTLs isolated from patient KPP94-024 were found to
recognze a.a. 221-232 on NS3. These results demonstrate that after symptomatic
secondar natual dengue infections in Thai patients, CTLs are mainly directed against
nonstrctual proteins and are broadly crossreactive. The data correlate with our
observations that nonstrctual proteins are immunodomiant proteins in volunteers who
received dengue vaccines.
We were interested in examinig CTL responses in children durg their acute
illness and comparg them to memory CTLs obtained from the same children a year or
more after the infection. A detailed analysis on samples from nine patients durng their
acute illness failed to generate any dengue virus-specific CTL responses. We therefore
decided to determine if cell mediated responses are altered durng acute dengue infection.
Decreased proliferative responses to mitogens and recall antigens have been observed in
V 11
PBMC obtained durng several acute human viral infections. All responses ofPBMC
during acute illness were compared to the same patients PBMC obtained at least 6
months after their infection. Proliferative responses to PHA, anti-CD3 , tetanus toxoid and
dengue antigens were significantly decreased in PBMC obtained durng the acute
infection. The proliferative responses to PHA were restored by the addition of gara-
irradiated autologous immune or allogeneic PBMC. Cell contact with the irradiated
PBMC was necessary to restore proliferation. Non- T cells ftom the acute PBMC 
dengue patients did not support proliferation ofT cells from control donors in response to
PHA, but T cells ftom the PBMC of patients with acute dengue proliferated if accessory
cells from a control donor were present. Addition of anti-CD28 antibodies restored anti-
CD3-induced proliferation of the PBMC of some patients. The percentage ofmonocytes
was reduced in the acute sample of PBMC of the dengue patients. Addition of IL-2 or
IL- , but not IL-4 or IL- 12 also restored proliferation of acute PBMC stimulated with
anti-CDJ.The results demonstrate that both quantitative and-.qualitativedefects in-the
accessory cell population during acute dengue illness result in a depression of in vitro T
cell proliferation.
The data generated from this project shed light on the nature of the immune
responses during acute natural dengue infections. It strengthens the existing data on the
human memory CD8+CTL responses to dengue viruses and validates the observations by
examining memory CTL responses after natural dengue infection in patients ftom
Thailand. In addition, we demonstrate a profound defect in lymphoproliferative responses
durg dengue illness.
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CHAPTER I
INTRODUCTION
There are estimated to be up to 100 millon cases of dengue infection each year
(Halstead, 1988). Dengue fever (DF) and dengue hemorrhagic fever/dengue shock
syndrome (DHF/DSS) affect people in South America, South and South-East Asia, the
Carbbean and Afrca and are caused by a group of antigenically related viruses called
dengue vises (Halstead, 1988). There are four serotyes of dengue virs designated
dengue 1 3 and 4 (Dl , D2 , D3 and D4) (Sabin, 1952). All four serotyes of virus can
cause the milder form of ilness (DF) and the more severe form of disease (DHF/DSS).
Dengue virus is transmitted to humans by mosquitoes belongig to the genus
Aedes. The species Aedes aegyti is the main vector although other Aedes species have
been known to transmit disease (Rodhai and Rosen, 1997). Ths species bites durng the
daytime and lives near humans, which accounts for higher inection rates among 
adult
women and children compared to adult men. Aedes aegypti is indigenous to the Southern
par of the United States, and in 1995 there were 7 cases ofDV infection reported in
Texas in individuals who did not travel outside the countr (CDC, 1996). The emergence
ofthe severe form of disease, DHF/DSS , as a public health problem is thought to be due
to the circulation of multiple serotyes of virs in areas with large populations and
mosquito vectors. Dengue fever occurs endemically or as epidemics in populations that
are predominantly non imune. These outbreaks occur tyically in the rainy season.
A. VIRUS STRUCTUR AN COMPOSITION
Dengue viruses (DV) belong to the family Flaviviridae, which includes Yellow
fever virus (YFV), Japanese encephalitis virus (JE) and West Nile virus (WN); the
majority of these viruses are arhropod borne (Monath and Heinz, 1996). DV contain a
single stranded positive sense RNA genome. The genome is about llKb long and
genome lengt RNAs appear to be the only virus-specific messenger RNA molecules in
infected cells. The genome encodes for 3 strctual and 7 nonstrctual proteins and the
priar translation product is synthesized as a single polypeptide that gets cleaved
cotranslationally or posttanslationally by viral and host proteases to produce the
different proteins (Chambers, et aI. , 1990) (Figue 1- 1).
The strctual proteins include the nucleocapsid (C), the membrane (prM) and the
envelope (E) proteins, and the genes that encode them are located at the 5' end of the
genome (2325 of the 10173 nucleotides). The C protein is the fist protein to be
synthesized durg viral translation. It is a highly basic protein and forms a strctual
component of the nucleocapsid (Henchal and Putnak, 1990). The prM protein is
synthesized as a precursor that is cleaved to a matue M and a nonM portion that is
secreted into the extracellular medium. The formation of the matue M is crucial for the
morphogenesis of the virion and results in an increase in viral infectivity (Randolph, et
aI. , 1990). The envelope protein (E) is thought to be important in several different
processes including viron assembly, receptor binding and membrane fusion (Kaufman, et
al. , 1987). It is the target for neutralizing antibodies, and mutations on E seriously affect
viral pathogenesis in experiental anmals. Neutralizing antibodies to E at
subneutralizing concentrations and nonneutralizing antibodies have been shown to
mediate antibody dependent enhancement (ADE) of infection (Kurane, et aI.
, 1991c).
ADE is a serological phenomenon in which productive viral infection of susceptible cells
(cells that bear Fc receptors for antibodies like monocytes and macrophages) is modified
by the addition of vis-reactive antibody at certain concentrations.
The xray strctue of the envelope protein oftick borne encephalitis (TBE), a
related flavivirus, has been solved (Rey, et aI., 1995). The complex is a head to tail
oligomer anchored to the membrane by its distal ends. The architectue of the E dimer
indicates that it is flat and extends in a direction parallel to the surface of the virion. This
is in contrast to the spike-like projection of the influenza hemagglutinin protein, which
has analogous fuctions.
Chen et al recently showed that a recombinant dengue virs envelope protein
expressed in Cos cells bound to heparan sulfate (HS) molecules on Vero cells
, and they
speculated that HS is the target cell receptor for DV (Chen, et aI., 1997). They showed
that highly sulfated HS inhbited binding and infectivity ofDV to 
a greater extent than
any low sulfate HS. Treatment ofVero cells with glycosaminoglycan (GAG) lyases,
which degraded heparn, prevented envelope protein binding; treatment ofDV with
suramin, a polyionic sulfate, also prevented inection. Others have hypothesized that 
is a priar receptor, which serves to localize the virus on the surace ofthe cell and
enhance the uptake of virs by an undentified high affity second receptor in close
proximity.
The genes encoding the 7 nonstrctual proteins, NSI-NS5 are found on the C
terminal two-thrds of the genome. The NSI glycoprotein, which is the soluble
complement fixing antigen, exists in cell-associated, cell-surface or extracellular
nonvirion forms (Lee, et aI. , 1989 , Westaway, 1987). The NS2a protein is important for
proteolytic processing of the NSI protein and the NS2b protein is involved in proteolysis
along with NS3 (Falgout, et aI. , 1989, Falgout, et aI. , 1993). The NS3 protein is the
second largest dengue viral protein (618-623 a. ) and is highly conserved among
flavivirses (Mandl, et aI. , 1989). At its N terminus it has sequence homology to trsin-
related serine proteases (Bazan and Fletterick, 1989). The C terminus shares homology
with a family ofRNA helicases and there is some evidence that this region is involved in
the capping and methylation of viral RNA (Gorbalenya, et aI. , 1989). The NS4a and 4b
proteins are hydrophobic with no known fuction as yet. NS5 , the largest protein (900-
905 a. ) is also highly conserved (Mandl, et al. , 1989). It is an RNA dependent RNA
polymerase and may be involved in RNA capping (Gru and Brinton, 1987 , Sumiyoshi
et aI. , 1987).
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B. CLINCAL SPECTRUM OF ILLNESS AN DIAGNOSIS
Dengue vis infections are often asymptomatic , but inection with any serotye
of dengue virus can cause a wide spectr of illness ranging from a viral fever (DF) to a
fatal hemorrhagic disease (DHF /DSS) (Burke, et aI. , 1988 , Halstead, 1980). If a person
gets infected with anyone serotye of dengue virus (primar infection) he has life long
imunty to that serotye , but no cross-protective immunity to the other three serotypes
(Sabin, 1952).
DF lasts about 5-7 days after an incubation period of a few days and is a self-
limited illness. The fever usually does not exceed 40. , and may retu to normal
durg the middle of illness. Some patients do not show this tyical ' saddleback fever
cure. DF is characterized by extreme malaise, muscleache, headache , backache, nausea
and vomiting. Development of a macular or maculopapular rash on days 2 to 6 of illness
is common. In 5-30% of cases , DF is associated with hemorrhage. The symptoms are
usually followed by defervesence and patients star to recover. Petechiae are seen at the
time of defervesence and last for a few days. Classical dengue fever is associated with
neutropenia, leukopenia, presence of atyical lymphocytes and thrombocytopenia (in 30-
50% of confirmed cases).
DHF occurs in a smaller number of patients but the early clincal featues ofDF
are indistinguishable from DHF. The characteristic featues ofDHF appear at the time of
defervesence when patients experience increased capilar permeability, resulting in
leakage of plasma into interstitial spaces. There is marked hemoconcentration
thombocytopenia and a prolonged bleeding time. The World Health Organzation
(WHO) clinical definition of dengue hemorrhagic fever includes continuous fever, a
positive tourquet test, hepatomegaly, thombocytopenia (.( 100,000/mm ) and
hemoconcentration (hematocrit increased by ;; 20% above baseline value). The WHO
established a grading system for the severity ofDHF (WHO, 1986), ftom less severe
(grade 1) to severe (grade 4). Grades 3 and 4 are also known as dengue shock syndrome
(DSS) in which plasma leakage is excessive resulting in hypovolemia and circulatar
shock. Without treatment, death wil occur in up to 50% of patients with DSS (Monath
and Heinz, 1996). It is common to detect pleural effusion durng plasma leakage in DHF
cases. Most patients recover from these severe symptoms with fluid replacement therapy
with no 10nglasting organ dysfuction.
Liver fuction tests (seru AL T and AST) are increased in patients with DF and
DHF (Kuo , et aI. , 1992, Nimmanitya, 1987). Kalayanarooj et al found that these
elevations are more common in the early stages of dengue than in other non-
dengue
febrile illnesses (Kalayanarooj, et aI., 1997). Severe gastrointestinal bleeding, which is
more common in DHF/DSS patients, may complicate the course of illness and can be the
direct cause of death. Hepatomegaly with hepatic failure may occur in severe cases.
c. PATHOGENESIS OF INECTION
1. Virulence of Virus Strains
Studies in some populations have suggested that increased virulence of certain
strains of virus cause DHF (Burke, et aI. , 1988 , Sangkawibha, et aI. , 1984). It is known
that dengue viruses differ in genotye and phenotye and these differences influence in
vitro experimental parameters such as plaque size. Propagation of dengue virus in
suckling mouse brais have yielded strains of viruses that have attenuated virulence in
humans (Sabin, 1952). However, varations in location of natual strais of dengue
viruses make any differences in the virulence among strains diffcult to assess.
Outbreaks of severe disease in the Americas have been associated with the
introduction of a dengue 2 genotye of Asian origin that has been associated with DHF in
that region (Gubler and Clark, 1995 , Rico-Hesse, 1990). These observations are diffcult
to interpret because durng ths time period there has also been increased circulation of
multiple serotyes of dengue virus. The data are not clear and defitive studies have not
yet been performed to indicate that certai strains of dengue virus cause DHF. The lack of
a suitable anmal model has also made identifyng markers of virulence difficult.
Burke et al and Sangkawibha et al suggested that infections with dengue virus
serotye 2 were associated with an increased risk for the development ofDHFIDSS
(Burke, et aI. , 1988, Sangkawibha, et aI. , 1984). Strais ofD2 virs associated with DHF
have been reported to replicate to higher levels in monocytes than DF associated strains
(Kliks, 1990 , Morens, et aI. , 1991). Other serotyes of virus were not examined in these
studies. Since DHF/DSS has been shown to occur afer infection with each ofthe four
serotyes of virus (Gubler and Trent, 1995), the concept that dengue 2 viruses cause
severe disease needs to be reexamned. Changes in the envelope sequence of the genome
have not been linked to disease severity amongst different strains of virus (Blok, et aI.
1989 , Chungue, et aI. , 1993 , Lee, et aI. , 1993). Research has been performed mostly on
the envelope protein and therefore this does not exclude the possibility that other regions
of the genome may be associated with severity of illness. Signficant differences in
viremia titres have not been detected between patients with DF or DHF; however recent
studies suggest that the degree of capillar leakage in DHF patients infected with dengue
2 correlated with levels of viremia (Vaugh et al unpublished data).
2. Immunopathology
a) Epidemiologic and pathologic evidence for immunopathogenesis ofDHF
There is considerable evidence that host immune factors play an important role in
determinig if a person develops DHF. Most of the evidence is epidemiological but these
strongly implicate prior exposure to the virus as a critical determnant of pathogenesis.
The overwhelming percentage of cases (80-90%) ofDHF occur durng secondar
infections, that is inection with a serotye ofDV other than that which caused their first
infection (Burke, et aI. , 1988, Guzan, et aI. , 1987 , Halstead, 1980). There are a minority
of cases ofDHF which occur durng priar infections. DHF durg priar infections
also occurs in inants 6-12 months of age who have anti-dengue IgG enhancing
antibodies from their mothers in their circulation (Kliks, et aI. , 1988).
DHF commonly occurs in areas where multiple serotyes of dengue virus are
circulating. In these areas people that are visiting for the first time experience classical
DF whereas those that live in the area appear to develop DHF from the same strain of
virs (Herrera-Basto , et aI. , 1992, Phillps, et aI. , 1992). Most of the cases ofDHF are
confed to have secondar inections by serologic testing. Cuba had an outbreak of
dengue 2 virus in 1981. Four years earlier, Cuba had experienced an outbreak with
dengue 1 after many years durng which the island had been free of dengue infections.
Children between the ages of 1-3 in 1981 who had no prior exposure to any other dengue
serotye, developed classical dengue fever. The majority ofDHF cases occured in the
age group above 4 years who had prior dengue infection in 1976 and in some infants
under 1 whose mothers were dengue antibody positive (Bravo, et aI. , 1987, Guzan, et
aI. , 1987).
Pathological studies of patients who died from DHF reveal no major organ
pathology, no sequelae post infection, vascular changes are non-specific and virus antigen
has been located only in cells of the reticuloendothelial cell comparent. The vascular
t,"
injures associated with severe disease may result from the direct destrction of
endothelial cells or by mediators that are secreted which alter the fuction of the cells
indiectly. Replication of dengue virses in endothelial cells has not been demonstrated in
vivo although the 4 serotyes of virs can infect these cells in vitro (Buttep, et aI.
1993). Dengue virs antigens have not been detected in vascular endothelial cells of
patients who succumbed to DHF. Electron microscopy has shown loss of integrty of
tight endothelial cell junctions (Sahaphong, et aI. , 1980). Most observations do not
support the direct destrction of cells by the virus but rather a fuctional alteration of
endothelial cells though the release of soluble mediators.
b) Antibody dependent enhancement of infection
Antibodies to certain viruses, including flaviviruses, have been shown to enhance
virus infection by a process known as antibody dependent enhancement (ADE) of
infection (Halstead, 1977a, Kurane, et aI. , 1991c). These antibodies are generally of the
IgG fraction, nonneutralizing and mediate their effect only at certain dilutions. ADE
requires bindig of the antibody to the FcyR on the monocytes because monoclonal
antibodies to the FcyR have been shown to inhbit ADE (peirs , et aI. , 1981) and
enzatic removal of the imunoglogulin Fc region blocks ADE but not neutralization.
The antibodies that mediate ADE in dengue are directed agaist the envelope and the prM
protein (Henchal, et aI. , 1985). The consequences of ADE in vivo could be to increase the
viral burden and/or altered tissue tropism (Halstead, 1977a, Halstead and O'Rourke
1977b) which could contrbute to the pathogenesis ofDHF. Eighty-five to ninety percent
ofDHF cases are seen in children over 1 year of age with secondar infections who could
theoretically have enhancing antibodies from their priar infection.
Kliks et al examned preinection sera of 40 children who subsequently developed
either DHF/DSS or had asymptomatic dengue infections. They showed that undiluted
sera from children (5/7) who developed severe disease (DHF/DSS) enhanced dengue-
virs infection of human monocytes while sera of children who had asymptomatic
secondar infections did not (Kiks, et aI. , 1989). Thus durng a secondar DV infection
a patient is likely to have circulating antibodies generated durng primar infection that
are crossreactive to the presently infecting serotye, but canot neutralize it. These data
were generated using a prototye strain of dengue 2 virus , not the virus strain that
infected the children. A lack of a suitable anmal model of dengue makes confirmation of
these observations in vivo diffcult.
c) Complement activation
Patients with DHF have been shown to have abnormal levels of different
complement components. Seru levels ofC3 , C4 and C5 are decreased and C3a levels
are increased (Malasit, 1987). C3a and C5a stimulate tissue mast cells to secrete
histamine and also help neutrophils move across the endothelium. Histamine is known to
cause formation of gaps between the endothelial cells. Immune complexes and
complement activation have also been shown to be present in patients with DF (Shaio, et
aI. , 1992). The exact role that complement plays in the pathogenesis of infection remains
unclear. It has been proposed that the high levels of antibody present in patients with
DHF may form immune complexes, which activate complement and cause immune
complex disease in the blood vessels. The alteration of seru levels of complement occur
durng the capilar leakage phase ofDHF; therefore they may be a response to another
stimulus that trggered the capillar leakage. To date no direct evidence exists to confirm
this hypothesis.
d) Role of T cells in Imunopathogenesis
The hypothesis of our laboratory is that T cells playa crucial role in the
immunopathogenesis of dengue disease. Several observations have been made by
analyzing patients samples which suggest that T cells play an important role in mediating
disease. In vivo evidence ofT cell activation has been shown by Kurane et al in the sera
of patients with dengue infections in Thailand (Kurane, et aI. , 1991a). Levels ofsIL-
sCD4 and sCD8 were more elevated in patients with DHF compared to patients with DF
which in tu were higher than normal controls. Atyical lymphocytes, which probably
include activated T lymphocytes, are seen in peripheral blood smears of patients with
acute disease (Kalayanarooj, et aI. , 1997 , Thisyakorn, et aI. , 1984). Although these data
do not conclusively prove that these T cells are the mediators of immunopathogenesis,
they suggest a potential for har that these activated T cells may cause.
D. CYTOTOXIC T CELLS AN THEIR POTENTIA ROLE IN DENGUE VIUS
INECTIONS
1. CTLs in clearance of virus infections
Cytotoxic T cells have been shown to play an important role in clearng and
recovery from viral infections. Virs-specific CTLs may exert their effects by directly
lysing virus-infected antigen presenting cells and/or releasing cytokines (including IF-
y and TN-a) and other factors with direct or indirect antiviral activity. Neutralizing
antibodies can prevent viral infections but only virus-specific CTLs can eliminate
established infections.
CD8+CTLs have been traditionally shown to be the major cytotoxic component of
the T cell subsets. Many studies in mice have demonstrated their role in the elimination
of virus-infected cells in vivo. CD4+ T cells were initially thought to only provide help
for CD8+CTLs to become activated and lyse foreign targets or help antibody producing B
cells. Many reports have since demonstrated virs specific CD4+CTLs in both humans
and mice. Although several reports have examined the role of CD4+CTLs in vivo
(Muller, et aI. , 1992 , Neal and Splitter, 1995 , Wijburg, et aI. , 1996), CD8+CTLs are
thought to be the main protective immune mechansm against several virus infections
Lukacher et al showed that influenza virus-specific CD8+CTLs of two
specificities protected recipient Balb/c mice from a lethal infuenza infection by reducing
pulmonar virs titers (Lukacher, et aI. , 1984). A subtye-specific clone protected mice
that were subsequently infected with a lethal dose of influenza virus in a subtye-specific
maner whereas a crossreactive clone protected mice infected with different subtyes of
virus. McIntye et al demonstrated the specificity of LCMV immune class I restrcted T
cells because they reduced LCMV spleen titres in mice infected with LCMV but they had
no effect on reducing titres of Pi chin de virus, a related arenavirus, in Pichinde virus-
infected mice (McIntye, et aI. , 1985). These results indicate the specificity of the T cell
clones , and suggest that direct contact between the killer and target cell is necessar for
elimnation of virs-infected cells, arguing against nonspecific mechansms that work
indirectly.
The main mechansm of direct lysis by CTLs is via the perforin/grane
pathway. Perf orin is a pore-forming protein that is released by the killer cell and causes
loss of plasma membrane integrty of the target cells leading to its eventual lysis and
elimination. Another mechansm by which infected cells are eliminated is the interaction
ofFas ligand on T cells with Fas , a molecule which can be constitutively expressed on
the APC' s. This interaction has been shown to induce apoptotic death oftarget cells.
2. Memo otoxic T lymphoc es in den e infection
Our laboratory has focused on characterizing and understanding T lymphocyte
responses to dengue inection. Most of these studies were performed on PBMC obtained
from young American volunteers who had received live attenuated monovalent dengue
vaccines as a priar infection. Kurane et al have demonstrated dengue virus-specific
cytotoxic T cells from these human volunteers (Kurane, et aI. , 1991b). Some ofthese T
cells were crossreactive with other serotyes of dengue virus indicating the potential for
them to be reactivated durng a secondar infection. Rothman et al 
have shown dengue-
specific T cells in the mouse which were crossreactive with other serotyes of virus
(Rothan, et aI. , 1996, Rothan, et aI. , 1993). Although CD4+ and CD8+ CTL
responses were detected, previously most studies were performed on CD4+CTLs.
Seven dengue virus-specific CD4+CTL clones were initially generated from one
donor who received a live dengue 3 vaccine (Kurane, et aI. , 1991b, Kurane, et aI.
, 1989b).
These T cell clones were analyzed in detail and were found to be directed against the
nonstrctual protein NS3. Numerous virus-specificities including virus subcomplex
specific (crossreactive with some but not all serotypes), virus serotye crossreactive and
also flavivirus crossreactive, were detected in these clones. At the bulk 
cultue level, the
dengue virus-specific proliferative responses were also serotye crossreactive
, though the
highest response was to the inecting serotye. Since then, CD4+CTL responses have
been analyzed in 5 dengue imune donors and many clones with varng patterns of
virus specificity have been characterized. Epitopes were mapped to C, E, NS I/NS2a and
NS3 proteins of dengue virus (Gagnon, et aI. , 1996 , Green, et aI. , 1993 , Green, et aI.
1997 , Kurane and Enns , 1994, Livingston, et aI. , 1994). CD4+ and CD8+ CTLs with
multiple specificities and against many different proteins (prM, E, NS I/NS2a and NS3)
were also detected in mice that had been inected with dengue- vis (Rothan, et aI.,
1996, Rothman, et aI. , 1993).
When this project was initiated, PBMC from one D4 immune donor had been
examined for CD8+CTLs in bulk cultue. Bukowski detected memory crossreactive T
cells directed against target cells expressing the strctual protein (E) or expressing
several nonstrctual proteins (NSI-NS4) (Bukowski , et aI. , 1989). Following the
demonstration of CD8+CTLs in bulk cultue , CTL clones were isolated from this donor.
The T cell clones generated recognzed the nonstrctual protein NS3 and were all
restrcted by HLA-B35 (Livingston, et aI. , 1995). Three patterns of specificities were
detected with these clones 1) serotye-specific 2) dengue subcomplex-specific (D2/4
crossreactive) 3) serotye-crossreactive (Dl/2/3/4 crossreactive). Epitopes were mapped
on NS3 using synthetic peptides and 3 of the clones recognzed a.a. 500-508 on D4NS3.
The serotye specific clone did not lyse targets expressing the corresponding peptide of
D2NS3 , whereas the crossreactive clones lysed D2NS3 expressing targets.
Many of the CD4+CTLs obtaied in our laboratory secrete IFN-y and IL-2 after
stimulation with dengue antigens and thus have a Thl cytokine profie. The T cell clones
established from imune individuals could thus contrbute to the cytokine milieu
proposed to be involved in DHF (Kurane, et aI. , 1989a, Kurane, et aI. , 1989b). T cells
may be activated by the antigen presenting cells and the activated T cells through the
release of soluble mediators such as cytokines can result in the abnormalities seen in
DHF. The fact that capilar leakage occurs quickly and there is no direct endothelial cell
damage, supports our hypothesis that locally acting cytokies may induce the plasma
leakage seen in DHF. Dengue viruses are lmown to infect cells of the reticuloendothelial
system including Kupffer cells in the liver, alveolar macrophages, and cells of the spleen
and thymus in vivo (Boonpuclmavig, et aI. , 1979, Yosan and Bhamarapravati , 1982). It is
possible that infection of these monocyte/macrophage cells lead to activation ofT cells
release of chemical mediators and activation of complement, all of which contribute to
disease severity. T cells may therefore have opposing roles, one in elimnating virs
infected cells which occurs in all dengue inections, but in some infections, the T cell and
other responses appear to trgger the immunopathogenesis of disease.
3. Cytotoxic T cells durng acute viral infections
Although the main fuction of CTLs is to help in control viral infection they have
III
also been shown to playa role in the immunopathogenesis of disease (Rouse, 1996);
Canon et al have shown that intravenous transfer of an RSV specific T cell line into
RSV -infected mice cleared the virs infection but also caused acute respiratory disease
(Canon, et aI. , 1988). Mice injected with 10 or more RSV-specific CTLs showed more
severe pathology on bronchoalveolar lavage. Mice injected with lower numbers ofCTLs
had less severe disease but stil cleared the infection. In murne LCMV infection, viral
clearance is mediated by CTLs but this is also associated with increased pathology
(Buchmeier, et aI. , 1980 , Kagi, et al. , 1996). Athymic mice that have been infected with
LCMV show no brain lesions and instead proceed to a persistent viral infection.
Therefore there is a fine balance between protective effects of CTLs and the deleterious
consequences that they may induce.
In humans, the fuction of CTLs during acute infections canot be studied in as
, .
) t
great detal. It is assumed that human T cells may also have dual effects in that they can 1 r
, f
clear virus in certain cases but may contribute to the immunopathology seen after some
viral infections. A number of studies have been done in patients infected with Epstein
I'": 
Bar Virus, which causes acute infectious mononucleosis. Strang et al isolated T cell
lines that could lyse autologous B lymphoblastoid cell lines (BLCL' s) ftom PBMC of 1::
I""
patients with infectious mononucleosis afer expansion in vitro with IL-2 and stimulator 111
cells (Strang and Rickinson, 1987). These CTLs had a complex pattern of recognition I'l
11;1
because they also lysed to varing degrees allogeneic targets with no shared HLA ji:1i
antigens. Schendel et al showed that CTLs with dual specificity could be isolated from
four unelated donors which lysed both HLA-C restricted EBV targets and allotargets
(Schendel, et aI. , 1992). Tomknson et al analyzed the alloreactive cytotoxic responses in
patients with infectious mononucleiosis and concluded that MHC class I expression was
suffcient for recognition because class I specific antibodies strongly inhibited lysis of
allogeneic targets (Tomkinson, et aI. , 1987). EBV antigenic expression was not required
on the allogeneic targets as the CTLs could lyse cell lines (HSB2 , HTL V- I and K562)
devoid ofthe EBV genome. Therefore, in acute EBV infection, CTLs which lyse both
virus-specific T cells that may contrbute to the recovery from infection and alloreactive
T cells that can lyse MHC incompatible target cells may be generated.
Kreth at al isolated mumps virus-specific CTLs that were MHC restricted from
the peripheral blood and cerebrospinal fluid of patients with acute mumps infection. In a
direct CTL assay the T cells lysed mumps virus-infected autologous PHA blasts but not
histoincompatible target cells (Kreth, et aI. , 1982). Demonstration oflysis by T cells
without in vitro stimulation indicated that the CTL were sensitized in vivo. These CTL
were virus-specific and showed no recognition of allogeneic target cells , unlike the
observation in acute EBV. HLA-restricted CTL have also been isolated in acute measles
and CMV infection in a small number of patients (Kreth, et aI. , 1979). Directly activated
CTLs have also been isolated in patients with persistent virus infections such as HIV-
and HTLV-
The above data and our interests in isolating dengue virus-specific CTLs in acute
disease initially warranted the examination of acute PBMC samples for in vivo activated
dengue-specific CTLs. The results from these studies prompted us to further explore T
cell responses in the acute samples obtained from the Thai children. They led us to
. '
analyze the in vitro unesponsiveness ofPBMC from samples obtained durng acute
illness.
E. IMOSUPPRESSION IN ACUTE VIR INECTIONS
Several viral infections have been known to cause a generalized suppression of
host imune responses. As early as 1905 , physicians observed that the morbidity of viral
infections was exacerbated by secondar bacterial inections, such as Haemophilus
influenzae and Streptococcus pneumoniae (Mils, 1984). Von Pirquet in 1908 noticed that
DTH responses to tuberculin were transiently depressed in PPD positive individuals
durng acute measles (V on Pirquet, 1908 , Wainberg and Mills , 1985). Tamashiro et al
showed that children with complicated measles illness remained skin test negative longer
(mean = 4 weeks after the appearance of rash) than children with uncomplicated illness
(mean = 2.3 weeks) (Tamashiro , et aI. , 1987). Measles kills nearly one million children
per year and a signficant proportion of these deaths is thought to be due to secondar
infections. Susceptibility to these secondar inections is thought to be the result of
immunosuppression seen following the acute measles virus infection.
Although viruses mediate their effects in multiple ways , they can alter the
fuction of the immune system in two general ways. Regulation of the immune system
Iii
If;
Iii
may be altered due to the direct replication of virus in immunocompetent cells. Viruses
such as HTL V- , HIV - 1 and certain paroviruses are lymphotropic and infection can
result in profound lymphopenia (Bloom, 1984, Dent, 1972 , Markham, et aI. , 1985).
Virses may diectly infect lymphocytes and lyse or fuctionally impair them (Measles
EBV, certain paroviruses) or they can inect and damage the antigen presenting cell
comparent namely the monocyte/macrophage comparent which is a critical
component in trggering a good immune response (Herpesviruses, infuenza, canne
distemper virus). The other major mechanism involved is indirect, and could involve the
release of antigens from the virus (feline leukemia vis) (Rojko and Olson, 1984),
soluble factors like lymphokies from host cells, and inbitors of lymphokie production
(Rodgers, et aI. , 1985). This latter mechansm could be an advantage for the virus
because relatively few infected cells could cause a wide ranging disruption in the entire
immune system by the release of immunoregulatory factors.
Viruses have varable cytopathic effects on host cells. Productive infection
leading to the replication of infectious virus, could result in a loss of vital cell fuctions
loss of membrane integrty, and eventual cell lysis (Figure 1-2). Other viruses, like
LCMV, HCMV and Measles, have restrcted viral replication in immune cells (Doyle and
Oldstone, 1978 , Joseph, et aI. , 1975 , Schrer, et aI. , 1985). The cell morphology remains
normal and there is no distubance of housekeeping fuctions, but specialized fuctions
of the cell, synthesis of products necessar for their immune fuction, are altered (Borrow
and Oldstone, 1995).
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Although there is in vivo evidence, of virus-induced immunosuppression, many of
the initial observations have been extended to in vitro systems. Smithwick and Berkovich
demonstrated that the proliferative response to tuberculin, of immune lymphocytes
isolated durng the course of acute measles infection, is depressed (Smithwick and
Berkovich, 1969). Several other investigators have examed the in vitro responses of
PBMC obtaied durng acute viral infections to specific antigens and mitogens.
Numerous cell surace molecules, and cytokies released from lymphocytes play an
important role in shaping the natue of the proliferative response.
1. Factors and cell surface interactions that may influence lym,phocyte proliferation
a). Interleukn- l (IL- l).
IL-la and IL- are proteolytically cleaved to the matue proteins (Paul, 1993). In vitro
many cell tyes secrete IL- l including monocytes/macrophages, T cells and endothelial
cells, but macrophages and keratinocytes are thought to be the main producers ofthis
cytokine in vivo. IL- l is generally considered a mediator of inflamation; it can
co stimulate T cell proliferation, increase IL-2 secretion and make dendrtic cells more
effcient APC' s. However, IL- l also induces production of corticosteroids and
prostaglandins such as PGE2 from T cells, which are known powerful inhbitors of T cell
proliferation. Macrophages secrete IL- , IL- , IL- , TN, prostaglandins, and
plasminogen activators in response to IL- l. Therefore, even though IL- l can promote
inflamatory responses, it can also have considerable negative effects on T cell
proliferation.
b). Interleukn-4 (IL-
IL-4 is secreted by T cells, provides help for B cells and stimulates growt and
differentiation ofTh2 cells (paul, 1993). It down regulates Thl tye cells and can also
affect macrophages. It decreases the expression ofIL- , IL-12 and IFN-y specifically and
attenuates the antiviral imune response. It can also alter IL-2 dependent in vitro
lymphoproliferati responses to varous antigens. DTH responses are classically
mediated by Thl cells and secretion ofIL-4 can suppress cell mediated immunty and
affect in vivo tuberculin responses.
c). Interleukn- l0 (IL- I0)
Produced by T and B lymphocytes and monocytes , IL- l 0 is known for its anti-
infamatory and imunosuppressive properties (Moore, et aI. , 1993). By affecting the
antigen presenting capacity ofmonocytes it can prevent antigen-induced proliferation of
PBMC and T cell clones. It can downegulate co stimulatory molecules, such as B7-
, B7-
2 and ICAM- l that are critical for the activation of T cells. It can induce long lasting 1(:
anergy in human CD4+ T cells. However IL- l 0 has also been shown to rescue human T
cells stared ofIL-2 from apoptotic death.
d). Interleukn- 12 (IL-12)
IL-12 is produced by phagocytic cells. It induces cytokie production, mainly IFN-
y, by
NK and T cells, favors Thl cell differentiation and promotes proliferation of
differentiated cells in response to specific antigens (Trinchieri, 1995). It enhances
proliferation of pre activated T cells to mitogens , alloantigens and anti-CD3 stimulation. It
has an obligatory role in antigen-induced Thl differentiation in vivo. A decrease in the
production ofIL-12 could therefore lead to a suppression of cell mediated immunty.
Known inhbitors oflL-12 include IL- I0, TGF- , IL- , IL-13 and PGE2.
e). Tumor Necrosis Factor (TN)
Monocytes and macrophages are the main producers ofTNF (paul, 1993). TNF is also an
inflamatory mediator and can increase the expression of cell adhesion molecules such
as ICAM- lon the surace of cells. It can activate phospholipase A2 (PLA2) an enzyme
, '
that cleaves arachidonic acid (AA) from phospholipids. AA has been reported to inhibit
IL-2 production in PBMC and T cell lines and have antiproliferative effects on T and B
cells. Therefore, increased production of these products diectly or via secretion ofTN
: '
may affect T cell proliferative responses in viral infections.
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f). Prostaglandins
Prostaglandins , also termed eicosanoids , are involved in development and regulation of
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immunological and inflamatory responses. PGE2 is known to inhbit secretion of
lymphokines and also affects T and B cell proliferation. PGE2 mediates its
antiproliferative effects by inibiting IL-2 production (Santoli, et aI. , 1990), inhbiting IL-
2 receptor expression, influencing cAM levels, and modulating the protein kiase C
pathway. It is maily thought to be released by monocytes. PGE2 appears to have a direct
inhbitory effect on T cells rather than acting through the APC's or generating other
suppressor populations.
g). B7-CD28 interactions
CD28 is expressed on 80% of human T cells and levels are increased upon T cell
activation (Lenschow, et aI. , 1996). B7-1 is expressed on activated APC' s and T cells and
maximal levels of expression occur 48-72 hours after stimulation. B7-2 is expressed on
resting monocytes to a low level and its expression is upregulated withi 6 hours of
stimulation. The CD28-B7 signaling pathway is one ofthe most important co stimulatory
pathways studied to date and is critical for the trggering of T cell activation. Blocking
this pathway using CTLA-4 Ig leads to inhibition of T cell proliferation and in some
cases induces T cell anergy or antigen-specific hyporesponsiveness (Yi-qun, et aI. , 1997).
Antibodies to B7- , B7-2 and CTLA-4 induced anergy of memory T cells to specific
antigens and this could be reversed by the addition ofIL-2 and autologous monocytes.
Cytokines differentially regulate expression of these molecules on APC' s and ths may
result in distinct effects durng an immune response.
III
h). CD2-LFA-3 and LFA- ICAM-
!i'
CD2 is expressed on all T cells and its interaction with its ligand LF A-3 initiates strong
antigen independent adhesion, induction ofIFN-y production, and expansion ofna'ive T
helper cells. The LFA- ICAM- l interaction also promotes cell adhesion and plays a role
in stimulating the proliferation of memory T cells. One or more ofthese molecules may
play an important role in affecting T cell responses durng acute viral infections
(Wingren, et aI. , 1995).
Viruses may affect both T cell and antigen presenting cell populations and
mediate their effects. Many studies have examined in vitro proliferative responses by
focussing on one cell population and concluded that the priar defect was due to either
abnormal T cells or abnonnal APC'
2. Effects of acute virus infection on the APC comparent
a) Monocyte/Macrophage involvement
) In vitro responses of acute PBMC obtained following viral infection in vivo
CMV is a heresvirus that causes an infectious mononucleosis-like syndrome.
PBMC of patients with acute CMV infection have dimished responses to mitogens
specific antigens and low production ofIF-y in vitro (Carey and Hirsch, 1981 , Kapasi
and Rice, 1988). Monocytes of patients with CMV infection may play an important role
in mediating suppression of immune responses, as the adherent cell population ofPBMC
could suppress the response of cultued lymphocytes in vitro. Patients at an earlier
clinical stage of illness (group 1 , approximately two weeks after the onset of symptoms)
had markedly depressed Con A responses; depletion of autologous monocytes or addition
of increasing doses of fresh autologous monocytes had no effect on proliferation of
PBMC. Depletion of monocytes from samples of patients at a later clinical stage
, (group
, three weeks after onset of symptoms) decreased Con A responses by 80% and addition
of fresh autologous monocytes improved proliferation. This indicated that monocytes
helped improve proliferation of T cells.
Mononuclear cells from 4 patients, who had CMV isolated from monocytes in the
PBMC were cultued for 7 days without Con A. On day 7 , the lymphocytes were
collected and compared with unseparated mononuclear cells that had also been cultued
without Con A for 7 days. The responsiveness of cultued lymphocytes from group 2
patients to Con A was reduced in the presence of autologous CMV -infected monocytes
by 72% whereas uninfected monocytes ftom control PBMC under similar cultue
conditions showed no suppressive effect. This indicated that CMV -infected monocytes
could suppress reactivity of cultued lymphocytes to Con A. Therefore, depending on the
cultue conditions, monocytes could either help or suppress lymphocyte proliferation.
PBMC obtaied from patients with measles 1-9 days after rash, from children
with other infectious diseases , and normal laboratory controls were evaluated for
suppressor activity (Hirsch, et aI. , 1984). Cells from these patients were cultued in PBS
or Con A for 4 days and then mixed with an equal number of normal donor cells treated
with mitomycin C. The percentage of suppression was calculated relative to the Con A
response of normal donor cells mixed with an equal number of fresh normal donor cells
treated with mitomycin. There were no differences between the control group and
measles patients in the ability of their cells, when precultued with Con A, to suppress the
response of fresh cells to Con A. However, only cells from measles patients when
precultured with PBS , suppressed Con A responses of normal donor cells. Infectious
virus was not detected in the cultue supernatants. The results suggested that a soluble
factor was responsible for suppressing the allogeneic Con A responses.
2.) In vitro responses following in vitro infection with a virus
Most of the research performed to date has examined in vitro responses following
in vitro infection witJ; different viruses. Human monocytes were infected with the
Edmonston strain of measles virus and stimulated with LPS , Staphylococcus aureus
Cowan strai 1 (SAC) or preincubated with IFN-y. Compared to unfected control
monocytes, the production of both the p40 and p70 unts ofIL-12 was downegulated in
infected cells (Kar, et aI. , 1996). Secretion ofTN-a , IL-6 and MIP- lj3 was not altered
by this stimulation. Soluble inhbitors ofIL- 12 production, IL- , TGF-j3, IL-4 and IL-
, were not detected in cultue supernatants, which implied that a direct interaction of
the virus with monocytes may be important. Crosslinkng of the measles virus receptor
CD46 also markedly decreased IL- 12 production and the authors speculated that reduced
production ofIL-12 from monocytes and macrophages leads to the suppression of cell
mediated immunty observed following acute measles infection. However, the authors did
not demonstrate that T cell proliferation to a varety of stimuli depended on IL-
secretion from monocytes. Other in vitro studies have shown increased IL- and
decreased TN-a production by measles virus-infected peripheral blood monocytes and
reduced capacity of the infected cells to present antigen (Griffn, et aI. , 1994, Ward, et aI.
1991).
Nokta et al showed that supernatants from monocytes infected in vitro with
CMV(Strains C-87 and AD-169) inhbited T cell proliferation by:; 95% (Nokta, et aI.
1996). This was associated with increased levels of cAM, arachidonic acid and PGE2
and increased TN -a release. A monoclonal antibody to TN and an inhbitor of PGE2
indomethacin, abolished the inhbitory effects of the supernatants. The authors concluded
that increased TNF-a-dependent release ofPGE2 induced antigen unesponsiveness ofT
cells in acute HCMV disease. Elevated levels ofTN-a have not been reported in
patients with acute CMV.
Gem et al showed that human rhinovirus (HV) binding to ICAM- l on
monocytes inhbited T cell proliferation to tetanus toxoid, candida antigens or varcella
zoster virus (VZV) but did not affect the response to mitogens and IL-2 (Gem, et aI.
1996). HRV was not directly toxic to T lymphocytes but rather mediated its effects by
affecting the antigen presenting cells.
b) Dendrtic cell (DC) involvement
Dendrtic cells are professional antigen presenting cells that are potent stimulators
of naive T cells to initiate T cell-dependent immune responses. High levels of expression
ofMHC Class II, adhesion and costimulatory molecules make DC' s very efficient
APC' s. Fugier-Vivier et al studied the effect of measles virus infection on CD40-
activated DC' s (Fugier-Vivier, et aI. , 1997). They found that measles virus replicated to
much higher levels in activated DC' s than in monocytes and induced syncytia formation.
Infection of DC' s resulted in decreased production ofIL-2 by T cells and rendered the T
cells unable to proliferate in co cultue experients. Both DC's and T cells were induced
to undergo apoptosis. They suggest that measles virus-infected DC' s in the PBMC are the
primar cell type that induce suppression ofT cell proliferation. This study, therefore, has
examined the role of DC' s following in vitro infection with measles virus; whether DC's
are infected in vivo durng acute measles infection is unown.
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Borrow et al analyzed the effect of an LCMV varant clone 13 on suppression of
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immune responses (Borrow, et aI. , 1995). This varant leads to persistent infection in
BALB/c ByJ mice. They found a CD8-dependent loss of interdigitating DC' s in the
. j' j": :;
I .spleen that resulted in an inability of APC' s from infected mice to stimulate a primar
MLR. However, PHA-induced T cell proliferation was not affected in these mice. They
conclude that CD8+CTL lysis of DC' s may be a mechansm of virus-induced
immunosuppression. Although DC' s may playa critical role in influencing the immune
response, there have been no reports that address the role of DC' s in mediating virus-
induced immunosuppression in PBMC from humans that have been infected in vivo with
a VIruS.
3. Effects of acute virus infection on the T cell comparent
a) Imunosuppressive T cell activity
In the early 1980' s several researchers noted an increase in CD8+ T cells which
they thought mediated suppressive activity (T ), or a decrease in the CD4+ T cell (T h
population and concluded that an abnormal ratio of T 
s / T h cells mediated the
immunosuppression seen following acute viral and bacterial infections. With
herpesviruses, such as EBV and CMV, an increase in the number ofCD8+ cells
following virs infection was noted (Carey, et aI. , 1981 , Reinherz, et aI. , 1980).
Diminshed mitogen responses in vitro and increased susceptibility to secondar
infections were associated with an abnormal CD4 to CD8 ratio (associated with an
increased number ofCD8+ T cells). These CD8+ T cells were thought to directly kill
helper T cells or secrete cytokines and other soluble factors which were antiproliferative
in nature.
In several experimental models of infectious diseases in mice, including HSV
Influenza and Reovirs inection, virus-specific suppressor cells were generated (Liew
and Russell, 1980, Rubin, et aI. , 1981 , Whtt, et aI. , 1984). However, most ofthe
studies did not show any conclusive proof that the Ts cells were directly responsible for
the effects observed. There was also no unified concept of how Ts cells worked in spite of
the demonstration of suppressor T cells in several different viral and bacterial systems
(Bloom, et aI. , 1992, Vijayakar, 1990). This area of research has not been active in
recent years.
b) Direct lympholysis
Some viruses can infect all lymphocytes , but tyically most viruses infect a
certain subtye of cells, e.g. T or B cells , resulting in a more selective defect in the
immune system. Canne distemper virus and some paroviruses directly infect
lymphocytes resulting in an inability to generate in vitro and in vivo immune responses
(Bloom, 1984, Krakowka, et aI. , 1975). This immunosuppression is thought to be parly
responsible for the secondar bacterial infections and neurologic involvement that affects
the anmals. HIV - 1 inects CD4+ T cells. Patients with AIS show decreased DTH
responses to many recall antigens and also impaired in vitro cell mediated responses
(Shanon, et aI. , 1985).
Some viruses have a direct effect on lymphocytes but the actual mechanism of
suppression may not be the result of direct lympholysis. EBV infects B cells primarly,
immortalizes them, induces polyclonal activation ofB cells and the production of
antibodies to EBV by specific cells. These infected B cells are thought to stimulate
atyical T cells, which may remove B cells from the circulation and may also account for
the anergy seen in cases of infectious mononucleiosis (Tosato , et aI. , 1979). Measles virus
can infect both T cells and monocytes in vitro and undergo restrcted replication in
unstimulated cells. In vivo the main cell population that is infected are the monocytes. It
is possible that productively infected T and B cells are removed early from the circulation
which accounts for the inability to detect measles virus in these populations.
c) Apoptosis of T cells
Over the last several years , studies have examined whether matue T lymphocytes
in acute viral infections undergo apoptotic death upon antigenic stimulation. Viruses may
sensitize T cells to undergo activation-induced cell death and this could be a general
mechansm of virus-induced imunodeficiency. T lymphocytes from patients with EBV
VZV and HIV have been shown to undergo apoptosis in vitro. CD4+ and CD8+ T
lymphocytes from patients with acute infectious mononucleosis, which are CD45RO+
were shown to undergo spontaneous in vitro apoptotic death (Tamar, et aI. , 1993
Uehara, et aI. , 1992). These activated cells could be rescued by the addition ofIL-2 to the
cultues , which resulted in an increase in bcl-2 expression ofthese cells. These T cells
were shown to have less expression of the bcl-2 protooncogene compared to T cells from
normal healthy controls. Bcl-2 is an antiapoptotic gene known to prolong cell surival in
activated, matue Band T cells. The results suggest that differential expression ofbcl-2 in
activated T cells may playa crucial role in determining the balance between T cell death
and surival following viral infections.
In acute LCMV infection, T cells die in vitro by activation-induced apoptosis
upon stimulation of the TCR-CD3 complex with anti-CD3 antibodies (Razi and Welsh
1993). Addition of recombinant IL-2 improved proliferation. However, in contrast to
EBV infection, IL-2 sensitized the T cells to undergo apoptosis upon TcR trggering.
Some memory cells against unelated antigens bear the high affinity IL-2 receptor, and
release oflL-2 durng an acute viral infection may cause these cells to actively cycle and
sensitize them to undergo activation-induced cell death. This would account for impaired
responses to recall antigens , such as tetanus toxoid, following an acute viral infection.
Therefore, depending on the cultue conditions and the state of the T cells, IL-2 can either
rescue cells or accelerate their apoptosis upon subsequent stimulation.
4. of Virus Infecti Induced Immunosuppression
To date there has not been any conclusive proof that one cell tye or factor is
responsible for the decreased T cell proliferative responses that have been seen during
acute virus infection. A great deal of controversy exists in several virus systems because
initial data suggested the predominant defect to be due to either T cells or APe's. The
observations are diffcult to interpret, and very few studies have been done to analyze
patients ' samples to understand which population of cells are responsible for decreased in
vitro proliferative responses.
Upon closer examination, researchers have found several defects in different cell
populations. The mechanisms that are involved in mediating the immunosuppression
induced by virus infections are probably multifactorial. Many viral infections are
associated with immunologic abnormalities. A single virus could theoretically affect
several ars of the imune system. They could be directly cytopathc for the host cells
(HIV, EBV), destroy virs infected target cells by antiviral immune effector mechansms
(LCMV, HI), impair the fuction ofthe infected cells (HCMV, Influenza), encode for
homologues of the immune system (EBV) that suppress immune fuction, trgger an
imbalance in the immune system by generating suppressor T cells (McChesney and
Oldstone, 1987 , Rouse and Horohov, 1986) or elicit autoimmune responses. These
strategies may enable viruses to evade host defense mechansms and persist longer in the
host.
In acute measles inection, defects have been found in the monocyte/macrophage
B cell, dendrtic cell and T cell comparents (Fugier-Vivier, et aI. , 1997 , Fujinami, et
aI. , 1998 , Griffi, et aI. , 1986, Kar, et aI. , 1996). The mechansms underlying the
immunosuppression following acute viral infections are complex and difficult to dissect
and interpret especially in humans. It is likely the decreased proliferative responses are
the result of trggerig of a complex network of cytokines and cell-surface interactions
involving both T cells and antigen presenting cells. There does not appear to be one
single general mechansm for the immunosuppression observed durg and following an
acute virus infection but rather a series of events trggered by a virus affecting several
components of the immune system directly or indirectly. Different viruses may use
different strategies to downegulate the immune system. This could result in common
defects in the lymphocyte/monocyte pool that are manfested as similar defective
responses in vitro to the different stimuli tested.
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F. QUESTIONS TO BE ADDRESSED AN AIS OF THIS THESIS
Fl. Human CD8+CTL responses to dengue vaccines
Only a limited analysis had been previously done on the CD8+ memory responses
to dengue virus. Therefore, a more detailed characterization ofthese responses in several
dengue-imune volunteers was performed in order to better understand the natue ofthe
CD8 responses to dengue virus. We wished to identify immunodominant proteins or
epitopes encoded by the dengue genome that were recognzed by CD8+CTLs. These
results would complement the available data on dengue-specific CD4+CTLs and
determine whether different proteins are recognized by these two distinct populations of
CTLs. These results would also be important when considering new approaches for
vaccine development and contrbute to the basic understanding of the immune response to
ths virus.
F2. Human CD8+CTL responses following natual secondar dengue infection
Dengue infections occur mainly in South and South East Asia, South America and
Afrca; therefore, analyzing CTL responses from patients who are natually infected with
DV is very important. Most ofthe research performed on human CTL responses to
dengue viruses had been in Caucasian volunteers who had no prior exposure to dengue
and therefore received the vaccine as a primar infection. The viruses used for the
vaccines were laboratory passaged in cell lines and were thought to be attenuated strains.
On the other hand, the complications seen in DV infection (DHF and DSS) are more
common in patients who have preexisting immunty to one serotype of virus durng
infection with another serotye (secondar dengue infection). Our laboratory was
therefore interested in analyzing CTL responses from patients after natual secondar
inections as it could provide insights into the mechansms of T-cell mediated
imunopathology.
F3. Immunosuppression durng acute dengue
Since a main interest of the laboratory is to better understand the role that T cells
play in the pathogenesis of severe dengue illness, we wanted to characterize the in vivo
activated T cells that were dengue-specific in the acute PBMC samples obtained from
children when they were admtted into the hospital. A second sample ofPBMC from the
same patients several months after infection to examine which population of cells would
become memory T cells. Results observed durng these experiments led me to investigate
the decreased in vitro T cell responses ofPBMC obtained durng acute dengue infection.
My specific ais were:
1. Analysis of bulk cultue memory CD8+CTL responses in 8 volunteers who received
live attenuated candidate monovalent dengue vaccines.
2. Analysis of memory CTL responses in Thai children following natual dengue
infection.
3. Analysis ofT cell responsiveness in Thai children during and after natural dengue
infection.
CHATER II
MATERIALS AND METHODS
A. VIRUSES
Dengue virus tye 1 (Hawaii strain) and dengue virs tye 2 (New Guinea C
strain) were provided by Walter E Brandt, Walter Reed Ary Institute of Research.
Dengue vis tye 3 (CH53489 strai) was provided by Bruce L. Ins, Ared Forces
Research Institute of Medical Sciences, Bangkok, Thailand. Dengue virus tye 4 (814669
strain) was provided by Jack McCown, Walter Reed Ary Institute of Research. Yellow
fever virus (YV) (17D strain) was provided by Jacob J Schlesinger, University of
Rochester School of Medicine and Dentistr. West Nile virus (WN) (EI01 strain) was
provided by Margo Briton, Georgia State University. Virses were propagated in C6/36
mosquito cells as previously described and frozen at -700 C until use (Kurane, et aI.
1984). Viral titres were 10 to 10 PFU/ml by plaque assays on CV- l monolayers.
Recombinant vaccinia viruses that contain the genes coding for dengue viral
proteins were produced as previously described (Falgout, et aI. , 1989 , Zeng, et aI. , 1996
Zhao , et aI. , 1989). Vaccina viruses expressing dengue 1 proteins were kindly provided
Table II-I Recombinant vaccinia viruses expressing different portons of the dengue
genome
c: prM. 1 E
NS2a NS3 INS4a
lNS4b lNS5 
Vac. Dl C.prM.
Vac. Dl E.NS1.2a
Vac. Dl
NS 1.2a.
Vac. D2 C.prM.
Vac. D2 NS1.2a
Vac. D2NS 1
Vac. D2NS3
Vac. D3 NS3
Vac. D4 prM.
Vac. D4 NS 1.2a
Vac. D4 NS3
The range of proteins expressed is listed based on the order of proteins in the flavivirus
polyprotein, C-prM- NSI-NS2a-NS3-NS4a-NS4b-NS5 (not drawn to scale),
where prM is the precursor to the membrane. The dengue proteins expressed by these
recombinant vaccinia viruses are designated based on the dengue serotye that served
as the source for cloning and the genome segment included.
by Dr. Enzo Paoletti, Virogenetics Co. ; those expressing dengue 4 proteins, dengue 2
prM.E (D2 C.prM.E) and dengue 2 NS l.2a (D2NS 1.2a) were kindly provided by Dr.
c.J. Lai , National Institutes of Health (N.1.H.). The other dengue 2 and dengue 3 vaccinia
recombinants were generously donated by Dr. Margo A. Brinton, Georgia State
University. Most of the recombinant vaccinia viruses used in this study are shown in
Table ll- l. The amino acids expressed by the trcations of the D3 and D4 nonstrctual
genes are indicated in parenthesis in the tables and figures.
B. PREPARTION OF A RECOMBINANT VACCINA VIRUS EXPRESSING THE
DENGUE 2 VIRUS NS 1 PROTEIN
RNA was extracted from the New Guinea C strain of dengue 2 virus using Ultraspec
reagent. cDNA synthesis was performed using a downstream primer specific for the
dengue 3' noncoding region ALD- 2 (5' -TCT CTC CCA GCG TCA AT A - ). The NSI
region was amplified by PCR using a specific 5' primer CTG TAT TTG GGA GTT ATG
GTG, which had an ATG in it for initiation of translation, and a 3' primer AGT GAA
AAG TTG TCA ATC TGC. The PCR product, which was 1112 bp in lengt, was cloned
into the vector pCR TM 2. 1. The pCR 
TM 2. 1 vector containing the D2NS 1 cDNA, was
digested with Spe I and Xho I, and the D2NS 1 cDNA insert was cloned into the vaccinia
virus recombination vector pSC 11. The pSC 11 vector was digested with XbaI and Hind
III to confirm the insertion of D2NS 1 cDNA, and from 1 of 10 clones fragments of the
right size were generated. CV - 1 cells were then transfected with the D2NS 1 cDNA insert
and infected with a wildtye vaccina virs. As a result of homologous recombination, the
vaccinia virus thymidine kinase (tk) gene was replaced by the D2NS 1 cDNA insert
rendering them tknegative. Afer 3 rounds of plaque purfication a recombinant vaccinia
virs was selected. The expression of the D2NS 1 protein in the vaccinia recombinant was
tested by immunofluoresence using rabbit anti NS seru followed by FITC horse anti
rabbit seru. The expression was also confed by infecting BLCL' s with the vaccinia
recombinant virus and using them as target cells in a CTL assay.
B. PREPARTION OF DENGUE ANTIGENS
Vero cell mono layers were infected with dengue viruses at a multiplicity 
infection of approximately 1 PFU per cell and incubated at 37 C in minmal essential
medium (MEM)I2% FBS until approximately 50% of the cells displayed cytopathc
effects (Kurane, et aI. , 1989a). Cells were then harested by scraping, washed, fixed in
i: '
025% glutaraldehyde in phosphate buffered saline (PBS) for 15 min on ice, washed
again and resuspended at 3 xl 0 cells/ml in RPMI 1640. The suspension of fixed cells was
' .
then sonicated on ice in a sonic dismembrator (Fisher Chemical Co.) and centrfuged at
1500xg for 10 min at 4 C. The supernatant was collected, aliquoted and frozen at -
as viral antigen. Control antigen was prepared similarly from uninfected vero cell
monolayers.
D. EXPEroNTAL VACCINS AN PBMC
All donors included in the studies had no detectable hemagglutinating-inhbiting
seru antibody to all four serotyes of dengue virus. They were immunzed
subcutaneously with undiluted vaccine viruses of the different serotypes as indicated in
Table II-2. They were proven to be infected with dengue virus by antibody responses and
virus isolation. Most of the volunteers had few symptoms (Bhamarapravati, et aI. , 1987
Green, et aI. , 1993 , Hoke, et aI. , 1990) and two had symptoms compatible with dengue
fever (Gagnon, et aI. , 1996, Ins, et aI. , 1988). PBMC were isolated at 4 months or later
after vaccination, resuspended at lxlO 7/ ml in RPMI 1640 with 20% FBS (Sigma) and
10% dimethyl sulfoxide and cryopreserved until use. HLA tying was performed in the
Tissue Typing Laboratory at the University of Massachusetts Medical Center -
Worcester.
E. STUDY DEFINTION AN SAMLES OBTAID FROM PATIENTS IN
THAAN
Blood samples were obtained from children enrolled in a prospective study of
dengue infections at the Queen Sirikit National Institute for Child Health (Bangkok
Children s Hospital), Bangkok, Thailand, and the Kamphaeng Phet Provincial Hospital
Kamphaeng Phet, Thailand, in 1994 (Kalayanarooj, et aI. , 1997 , Vaughn, et aI. , 1997).
TABLE 11-2 Summary of Vaccination and HLA Class I Types of Donors
who received live attenuated experimental dengue vaccines
DONOR # SEROTYE OF MONTHS AFTER
ACClNE VACCINATION CLASS I HLA TYPE
RECElVED* PBMC OBTAINED
, 11
, 28
Virus strains administered were: dengue- l strain 45AZ5 (McKee, et aI. , 1987), dengue-
strain 16881 (Dharakl, et aI. , 1994), dengue-3 strain CH53489 (Ins, et aI. , 1988) and
dengue-4 strain 341750 (Gagnon, et aI. , 1996).
We than Sharone Green, David Vaughn and Ananda Nisalak, who supplied us
with these valuable specimens. We thank the nurses and pediatricians at the Queen Sirkit
National Institute of Child Health and the Kamphaeng Phet Provincial Hospital, Thailand
for volunteer enrollment and patient management. We than the research nurses
technicians, technologists, and administrative personnel ofthe Deparent of Virology,
AFRIMS for specimen collection, specimen processing, and data management. We also
than the patients and their families for their participation in this study.
Previously healthy children who presented to either hospital with fever of 72 h or
less in duration and facial flushing without an obvious cause were eligible to paricipate
in this study. Children who had an identifiable cause of fever ( e.g. those with measles,
sinusitis , gastroenteritis) were excluded from the study. A diagnosis of acute dengue
infection was based on serologic tests (antibody capture EIA and hemagglutination-
inhibition HAl) and isolation of dengue virus (in Toxorhynchites splendens mosquitoes).
Clinical diagnoses ofDF and DHF were assigned according to WHO criteria
(Anonymous , 1997). Standard serological criteria were used to identify an acute primary
,.,
or secondar dengue infection. A diagnosis of secondary dengue infection was made
based on the following criteria: a) a dengue IgM-to-IgG ratio of -: 1.8: 1 , b) a 2- fold
increase in IgG to dengue between acute and immune samples, with an absolute value of
100U in the absence of IgM to dengue of 40U c) A HAl titer of:; 1 : 1280, one week
after the onset of illness.
For all the analyses done in Chapter IV, PBMC samples obtained from 4 patients
12 months after infection were used as indicated in Table II-3. HLA- , Band C class I
typing was performed using a standard microlymphocytotoxicity assay, and HLA class II
typing was performed by PCR-based amplification and hybridization with HLA-DRB1
DRB3 , DRB5 , DQA1 , DQBl and DPBl sequence-specific oligonucleotide probes as
previously described (Chandanayingyong, et aI. , 1997). Four subjects with documented
secondary dengue-2 or dengue-4 virus infections were selected for this study.
Study day 1 was defined as the calendar day the subject was enrolled in the study.
For the studies performed in Chapter V , a sample was considered to be an acute sample
up to study day 11, although the subjects were not febrile at that time. Immune samples
were obtained from the same patients 6 months or later after their acute infection. All
sample numbers in Chapter V are denoted by the study days on which the samples were
obtained. Fever day 0 was defined as the calendar day during which the temperature fell
and stayed .. 38 C, and days before and after this point were numbered consecutively
(fever days -
, -
2 etc. occurred before defervesence and fever days +1 , +2 etc. occurred
after defervesence). Patient information and the diagnoses are given in Table II-4. Sample
numbers indicate acute (A) or immune (I) PBMC and the study day on which they were
obtained. PBMC obtained ftom patients during and after their illness (acute and immune
samples) were separated and cryopreserved in liquid nitrogen. Frozen PBMC samples
were shipped to the University of Massachusetts Medical Center for testing.
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Table 11-4 Patient information and clinical diagnosis of study subjects from
Thailand involved in the acute T cell studies
PATIENT DIAG- SERO- SERO- ACUTE/ STUDY FEVER
NOSIS a LOGY b TYPE IME DAY DAyd
BLEED C
1 (CHD94-090) 1 u , +6
374
2(CHD94-067) 1 u , 11 , +8
368
3(CHD94- 139) , +1
354
4(KPP94-0 17)
366
5(CHD94- 115)
725
6(CHD94-089) , +7
725
7(CHD94- 118) , +1
367
8(KPP94-013)
364
9( CHD94-094) DHF Gr 
336 , 725
1 O( CHD94-073) DHF Gr 2
368
11(CHD94-020) DHF Gr 2 , +1
367 , 724
12(CHD94- 138) DHF Gr 2
354
13(CHD94-095) DHF Gr 2
196
14( CHD94- 134) DHF Gr 3
372
15(KPP94-041) DHF Gr 3
366
16(KPP94-035) DHF Gr 3
17(CHD94-081) DHF Gr 3
a DF 
= dengue fever, DHF = dengue hemorrhagic fever. 
b 1
= primar infection, 2
secondar infection. C A = acute PBMC samples, I = immune samples
d Fever day 0 = calendar day when the temperatue fell and stayed -( 3S
Written consent was obtained from each subject's parent or guardian. The study protocol
was approved by the Institutional Review Boards established by the Ministry of Health
Thailand, the Surgeon General' s Office of the Departent of the Ary, and the
University of Massachusetts Medical Center.
F. PROLIFERATIVE RESPONSES OF PBMC FROM DENGUE VACCINE
RECIPIENTS AND THAILAND DONORS
Proliferation assays were performed as previously described (Kurane , et aI.
1989a). PBMC (2X 10 5) from vaccine recipients were cultured with the different
flaviviruses at various dilutions in 0.2 ml of AIM-V medium (GIBCO BRL Life
Technologies, Gaithersburg, MD) containing 10% heat inactivated human AB (Hu ABS;
Advanced Biotechnologies Inc, Columbia, MD) serum (AIMIlO%) in duplicate or
triplicate wells of 96-well round-bottom microtiter plates (Costar, Cambridge , MA) at
C for 7 days. PBMC from patients in Thailand (both the acute and immune phase of
infection at 105/well) were thawed, resuspended in AIMIlO% medium and added to a v-
bottom 96 well plate in the presence of either PHA (1:1000), anti-CD3 (l2F6; provided
by Johnson Wong, Massachusetts General Hospital) (O.lllg/ml), or with the indicated
concentrations of other antigens. When cytokines were added to the wells , 10U/ml of
recombinant IL-2 (Collaborative Biochemical Products , Bedford, Mass.), 100U/ml ofIL-
4 (Genzyme), 100U/ml ofIL-7 (Genzyme) or 25 ng/ml ofIL- 12 (Genetics Institute,
Cambridge, Mass. ) were added to PHA-stimulated or anti-CD3 stimulated cells. lx1Q5
gamma-irradiated (3500 rads) autologous immune PBMC or allogeneic PBMC ftom
healthy control donors were added to wells containing PBMC ftom acute dengue patients
as indicated. The anti CD28 antibodies were purchased ftom Pharingen and used at a
concentration of 5 or 10 !-g/ml together with the anti-CD3 antibody 12F6 (0. 1 !-g/ml).
The negative controls were cell suspensions in medium alone without any stimulation.
Optimal concentrations of antigens were determined using PBMC of control donors.
Cells were incubated for 5-7 days as this was shown to be optimal for proliferation using
cells/well. The cells were pulsed with 1.25 !-Ci of 3H thymidine (3H TdR) on day 4
after the PHA or anti CD3 stimulation or on day 6 for tlavivirus antigens and tetanus
toxoid for approximately 18 hours before harvest onto filters with a multi harester
(Titertek; Skatron Inc, Sterling V A). 3H- TdR incorporation was counted in a liquid
scintillation counter (1205 Betaplate; Pharacia, Wallac Oy, Finland). Significant virus-
specific proliferative responses after immunization were defined using the following
criteria: (Dharakul, et aI. , 1994) the maximum stimulation index (SI) induced by each of
the tlaviviruses had to be two or more times greater than that induced by control antigen
at the same dilution, the differences had to be statistically different and 3H- TdR
incorporation had to be greater than 1000 cpm.
G. BULK CULTUR OF PBMC.
PBMC from donors who received the live attenuated monovalent vaccines (data
in Chapter III) or patients from Thailand (data in Chapter IV), were cultued at
approximately 2-5xl0 6/ well in AIIO% medium with the homologous dengue virs
at a final dilution of stock virus between 1 :2- 1:6 in 24 or 48 well cluster plates. Virus-
stimulated cells from most of the vaccine donors were tested in bulk culture CTL assays
between days 7-
In certain cases, cells were restimulated on day 7 with gama irradiated (3500rad)
autologous PBMC in 1 ml of fresh medium containig 10% HuAs , 10U/ml IL-2 and
dengue virus (for vaccine donors). Restimulated cells were assayed 7 days later for
cytolytic activity. For the patients in Thailand, cells were restimulated with 1 x 10
gama-irradiated (3500 rad) allogeneic PBMC and anti-CD3 monoclonal antibody 12F6
(0. 1 J.g/ml), kindly provided by Johnson Wong, Massachusetts General Hospital in 0.
ml of fresh medium containing 10% Hu ABS and 25-50U/ml of recombinant IL2
(Collaborative Biochemical Products, Bedford MA) as indicated. Bulk cultues were
restimulated every two weeks and cells were assayed 7- 1 Od after the last restimulation for
cytolytic activity in CTL assays.
H. CLONIG OF PBMC.
Immune PBMC (Chapter IV) which had been stimulated in bulk culture for 7 days
were collected, and plated at a concentration of 10 and 30 cells per well in 96-well round-
bottom microtiter plates in 200J-l of AIM/I 0% medium, 10 allogeneic gama-irradiated
PBMC , anti-CD3 (0. J-g/ml) and 25U/ml IL2. Every 3-4 days cells were fed with ftesh
AIM-V medium containing 10%Hu ABS and 25U/ml IL2. Cells were restimulated with
allogeneic PBMC and IL-2 every 2 weeks. The T cell lines were initially screened in
cytotoxicity assays using target cells infected with vaccinia recombinants expressing
dengue proteins. Growing cells that showed positive lytic activity against any dengue
protein were expanded into 48-well plates (Costar) and restimulated with 10 allogeneic
PBMC and anti-CD3 in a final volume of 1 ml.
1. ESTABLISHMENT OF LYMPHOBLASTOID CELL LINS
Lymphoblastoid cell lines (BLCLs) were established by culturing PBMC
(approximately 2xl0 ) with EBV from an infected maroset cell line, B95-8 (American
Type Culture Collection) in RPMI 1640 containing 20% FBS , penicillin, streptomycin
glutamine and HEPES. Cyclosporin A was added at a final concentration of 1 J-g/ml.
J. CELL SURACE ANTIGEN ANALYSIS
Approximately 4-5x 1 0 T cells were washed with cold PBS and stained with
fluorescein isothiocyanate-conjugated (FITC) anti-CD4, anti-CD8 or control IgG
antibodies for 30 minutes on ice. The cells were washed in PBS and fixed with 4%
paraformaldehyd for 7 minutes. The lines were washed again and analyzed for CD4 or
CD8 expression using a fluorescence microscope. FITC-conjugated monoclonal
antibodies to CD14 and CD19 were purchased from Pharingen (San Diego , CA). The
FITC-conjugated CD3 , CD4 and CD8 antibodies were purchased from Beckton
Dickinson. FACS analysis was performed on unstimulated acute and immune PBMC
(approximately 1-3x 1 0 cells).
K. PEPTIDE SYNTHESIS
Peptides were synthesized with the RAPS multiple peptide synthesis system
(New England Nuclear Products, Boston, MA) or the Symphony peptide synthesizer
(Rainin Instruments, Wobum, MA) at the University of Massachusetts Peptide Core
Facility.
L. PREPARTION OF TARGET CELLS.
BLCLs (approximately 5xl05 ) in RPMII0% FBS were infected with vaccinia
virses for 1.5 - 2 hours at 370C. The cells were then diluted in 2 mls of media and
fuer incubated for 12 - 16 hours. Target cells were then washed and labeled with 0.
mCi of 51Cr (Dupont NEN, Boston, MA) for 60 mins at 370C. Afer four washes 
remove unncorporated 51 Cr, target cells were counted and diluted to 10 4 cells/ml for
use in the cytotoxicity assay. The allogeneic target cells used in the assays were either
produced in our laboratory in Massachusetts from unelated donors or obtained ftom the
National Institutes of General Medical Sciences (NGMS) Human Genetic Mutant Cell
Repository or the American Society for Histocompatibility and Imunogenetics (ASHI)
Cell Ban and Repository.
M. 51 Cr. RELEASE CYTOTOXICITY ASSAYS.
Cytotoxicity assays were performed in 96 round-bottom plates as previously
reported (Bukowski, et aI. , 1989). Effector cells were added to lxl0 3 51 Cr-labeled
target cells at an effector to target (E:T) ratio of approximately 100: 1 in bulk cultue CTL
assays and at the indicated E:T ratios when T cell lines were tested. In CTL assays with
synthetic peptides, peptides at the indicated concentrations were added to target cells and
incubated at 370C for 30 min, after which effector cells were added. Plates were
centrfuged at 200 x g for 5 mins and incubated for 4-5 hours at 370C. Supernatant fluids
were harested using the supernatant collection system (Skatron) and 51Cr content was
measured in a gama counter. The percent specific 51 Cr release was calculated with the
following formula: (cpm experimental release - cpm spontaneous release )/( cpm
maximum release - cpm spontaneous release) x 100. Maximum values were obtained by
incubating target cells alone with a detergent and spontaneous values were obtained by
incubating target cells alone with media. All assays were performed in trplicate, and the
results were calculated from the average of the trplicate wells. The standard error of the
mean was less than 10% in all of the experiments.
N. MONOCLONAL ANTIBODY DEPLETION ASSAYS .
Anti-OKT3 (CD3), anti-OKT4 (CD4), anti-OKT8 (CD8); ( all from Orto
Diagnostic Systems, Inc. , Rartan, N.J.) and anti-Leullb (CDI6; Becton Dickonson Co.
antibodies were used in antibody-complement depletion assays. Dengue virus-stimulated
effector cells (1- 1.5xlO 6) were resuspended in 0.5 ml ofRPMI 1640 supplemented with
2% FBS with 50 l of the individual antibodies. Following 30 mins. of incubation at 40C
the cells were washed twce in cold RPMI/2% FBS and then resuspended in 0.6 ml to
which 0.2 ml of rabbit complement (Cedarlane Laboratories, Hornby, Ontaro , Canada)
was added. After 60 mins of incubation at 37 OC , cells were washed three times
resuspended in RPMI/l 0% FBS and then used as effector cells in cytotoxicity assays.
O. CELL SEPARTIONS
2xl0 PBMC from patients with acute dengue or control healthy donors were used
to isolate T cells using anti-CD4 and anti-CD8 coated magnetic beads (Dynal MPC).
After the CD4 and CD8 coated beads adhered to the magnet, the remaining cells were
collected and used as a source of non- T cells. The non- T cell population was irradiated
(3500 rads). As controls , unfractionated PBMC ftom both acute dengue patients and
control healthy PBMC were stiulated with PHA.
P. TRAS WELL EXPERINTS
PBMC from 4 patients with acute dengue infection and control allogeneic PBMC
were resuspended at lx10 /ml in AII0% medium. The transwells (Costar, Cambridge
MA), consist of a lower and upper comparent which are separated by a polycarbonate-
treated membrane with pores of 0.4 Ilm in size. 100 III of acute or control PBMC were
added to the upper well of the transwell and 600 III of media were added to the lower well
with PHA at a final concentration of 1: 1 000. For co cultue experients , acute PBMC and
gama-iradiated allogeneic PBMC were cultued together in 100 III in the upper well 
the transwell as a positive control. To see if cell contact was essential to increase
proliferation, 100 J.l of the acute PBMC were transferred to the upper well and 600 J.l of
gama- irradiated, allogeneic PBMC were transferred to the lower well with PHA at
1:1000. The plate was incubated at 37 C. On day 4, 75 J.l ofthe cell suspensions from the
upper and lower wells were transferred to a 96 well plate in a final volume of 200 J.l
pulsed with 1.25 J.Ci oeHTdR and harested approximately 18 hours later.
CHAPTER III
ANALYSIS OF CD8+ T CELL RESPONSES OF PBMC FROM DENGUE
VACCINE RECIPIENTS
'\. '
A. LYMHOCYTE PROLIFERATIVE RESPONSES TO FLA VIIRUSES
We first examined the proliferative responses ofthe PBMC from all 8 donors who
received monovalent live attenuated dengue vaccines to different flaviviruses including
dengue viruses. Uninfected supernatants ftom C6/36 mosquito cells were used as a
negative control in these assays. Proliferation was measured on day 7 by uptake of 3H-
TdR. Previous studies have shown that both dengue virus-specific CD4+ and CD8+ T
cells can be stimulated in ths assay (Bukowski, et aI. , 1989). All 8 donors had signficant
proliferative responses to one or more of the viruses tested (Table III- I). The PBMC of
all the donors responded strongly to the serotye that they had been vaccinated with and
the PBMC of most donors responded to a lesser degree to the other serotyes of dengue
virus, West Nile virus or Yellow fever virus. These results suggest that dengue virus
specific memory T lymphocytes from the eight donors after primar dengue virus
infection are predominantly serotye-specific and that crossreactive cells are also present.
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B. PROTEIN SPECIFICITY OF CTLs GENERA TED FROM PBMC OF DENGUE
IM DONORS
We next analyzed the CTL responses to different dengue proteins in PBMC of
these vaccine recipients. BLCLs were infected with vaccinia recombinants expressing
portions of the dengue genome (Table II-I) and used as target cells in cytotoxicity assays.
The effector cells generated from PBMC of donor 1 , who was immunzed with a
monovalent Dl vaccine, lysed targets expressing the Dl strctual proteins C.prM.E and
also those expressing the E and NS1.2a proteins (Table 1II-2 exp 1). CTLs from donors 2
and 3 who received a D2 vaccine, recognized target cells expressing the three D2
strctual proteins C.prM.E (Table III-3 exp 1) and were fuher shown to lyse target cells
expressing only the envelope protein E (Table III-3 exp 3 ), indicating that specific killing
was directed against the envelope protein. CTLs from both these donors also recognized
recombinant vaccinia viruses expressing the nonstrctual proteins NS1.2a and NS3. On
the other hand, CTLs from donor 4, who received the same D2 vaccine demonstrated no
lytic activity against any of the strctual proteins but recognzed the nonstrctual
proteins NS1.2a and NS3 (Table III-3 exp 1 ). Using target cells expressing D3NS3
CTLs from donor 5 , who received a D3 vaccine, were found to recognze the
nonstrctural protein NS3 (Table III-3 exp 1 ).
Donor 6 had memory CTL responses against the prM (precursor of the
membrane) and NS3 proteins. Target cells expressing the strctual proteins
, .
TABLE 111-2 Recognition of dengue virus proteins by CTLs
generated from PBMC of Dengue-l immune donor 1 *
Target cells infected with % Specific Cr release
Exp. 1 Vac. Dl (C.prM.
Vac. Dl (E.NS l.NS2a)
V ac. (control)
Exp. 2 Vac. Dl (C.prM.
Vac. Dl (E.NS1.NS2a)
Vac. D2 (E)
Vac. D2 (C.prM)
Vac. D2 (NS1.NS2a)
Vac. D4 (E)
V ac. (control)
Autologous target cells (10 ) were infected with DVNV recombinants and
incubated with effector cells for 4-5 hours. The effector/target ratio was
approximately 100:1.
Donor 1 PBMC were stimulated twice in vitro with D 1 V.
Donor 1 PBMC were stimulated once in vitro with DIV.
TABLE 111-3 Recognition of dengue virus proteins by CTLs generated from
PBMC of dengue-2 immune donors 2, 3, 4 and dengue-3 immune donor-
% Specific SICr release
Target cells Donor 2 Donor 3 Donor 4 Donor 5
infected with (D2) (D2) (D2) (D3)
Exp. Vac.D2 (C.prM.
Vac.D2 (C.pr.
V ac.D2 (E)
Vac.D2 (NSl.2a)
V ac.D2 (NS3)
Vac.D3 (NS3)
Vac. (Control)
Exp. Vac.D2 (NS3)
Vac.D3 (NS3)
Vac.D4 (NS3)
Vac. (Control)
Exp. 3 Vac.D2 (E)
V ac.D4 (E)
Vac.D2 (NS1.2a)
V ac.D 1 (ENS 1.2a.2b)
Vac.D4 (NS1.2a)
Vac. (Control)
PBMC from Donors 2-5 were stimulated with autologous virus once in vitro. The
effector/target ratio was approximately 100: 
t The effector target ratio was approximately 200: 1 for donor 2.
:".
TABLE 111-4 Recognition of dengue virus proteins recognized by CTLs generated
from PBMC of dengue- immune donors 6,7 and 8
% Specific Cr release
Target cells Donor 6 Donor 7 Donor 8
infected with (D4) (D4) (D4)
Exp. Vac. D4 (C.prM.
Vac. D4 (pr.
V ac. D4 (E)
Vac. D4 (NS 1.2a)
Vac. D4 (NS3)
Vac. (Control)
Exp. Vac. D2 (NS3)
V ac. D3 (NS3)
V ac. D4 (NS3)
V ac. D2 (NS 1.2a)
Vac. Dl (E.NS1.2a)
Vac. (Control)
PBMC were stimulated with D4V twice for donor 6 and once for donors 7 and 8
as described in Materials and Methods. Effector/target ratio was approximately 100: 
(D4 C.prM.E), were lysed by donor 6 bulk cultues (Table 111-4 exp 1). We then narowed
the response down to the prM protein using target cells expressing the individual
strctual proteins. This is the first time a T cell response has been detected against the
prM protein. CTLs from donor 7 recognzed the envelope protein (E) and nonstrctual
protein NS3 (Table 111-4 exp 1). Our laboratory has previously detected CD8+ CTL
clones from this donor that recognzed the NS3 protein. CTLs from donor 8 mainly
recognzed target cells expressing D4 NS1.2a and the E protein to a lesser degree (Table
111-4 exp 1).
The results from the above experiments indicate that CTLs were generated against
at least one viral protein in all 8 donors. The dengue proteins predominantly recognized
by CTLs were the nonstrctual proteins NS 1.2a and NS3 and the envelope protein E.
C. MAPING OF THE prM EPITOPE RECOGNIED BY PBMC OF DONOR 6
To define the on epitope the prM protein recognzed by donor 6 PBMC, we used
constrcts that expressed the cleaved portion (nonM) and the matue portion (M) of the
prM protein to infect targets for use in a CTL assay. We found that the nonM portion was
recognized by Donor 6' s CTLs in bulk culture (Table 111-5 expo 1). Using overlapping
15mer peptides that spaned the entire nonM protein, we found that a.a. 1- 15 (peptide
prM #1) on the nonM protein was lysed by bulk cultue CTL (Table 111-5 expo 2). Furher
analysis using a dilution ofthe peptide indicated that prM peptide #1 was recognzed at a
Table 111-5 Recognition of amino acids 1-15 of the D4V
pr.M protein by bulk culture CTLs generated from Donor 6
% Specific 
release
Target cells
infected/pulsed with
Exp. 1 Vac. D4 prM.
Vac. D4 nonM.
Vac. D4 M
Vac. D2 nonM
Vac. control
Exp. Vac. D4 nonM
No peptide
#1 (a. 15)
#2 (a. 22)
#3 (a.a.l5-29)
#4 (a.a. 22-36)
#5 (a.a. 29-43)
#6 (a.a.36-50)
#7 (a.a.43-57)
#8 (a. 50-64)
#9 (a.a. 57-71)
Table 111-5 continued
Exp.
Vac. control
Vac. D4 nonM
No peptide
#1 (1- 15) 25 jlg/ml
#1 (1- 15) 2.5 jlg/ml
#1 (1- 15) .25 jlg/ml
#1 (1- 15) .025 jlg/ml
#10 (a.a. 64-78)
#11 (a.a. 71-85)
#12 (a.a. 78-92)
# 13 (a.a. 85-99)
PBMC were stimulated with D4V twice for donor 6 as described
in Materials and Methods. Effector/target ratio was
approximately 100: 1. Targets were pulsed with 25 jlg/ml of the
indicated peptide unless otherwise stated.
j .
analysis using a dilution of the peptide indicated that prM peptide #1 was recognized at a
concentration of .025 J.g/ml (Table III-5 expo 3). This is the first CTL epitope that has
been detected on the nonM portion of the prM protein.
D. SEROTYPE SPECIFICITY OF CTLs GENERATED FROM PBMC OF DENGUE
IMMU DONORS
To analyze the serotye specificity of the CTL responses in all donors we used
target cells expressing dengue proteins of serotypes other than the one used to immunize
the donor. For donor 1 , the CTL response was serotype-specific, as target cells expressing
dengue proteins ftom serotypes other than Dl were not recognized (Table III-2 expo 2).
For donor 2 , the responses to E and NS1.2a proteins were serotype-specific (Table III-
expo 3) whereas recognition ofNS3 was cross-reactive with D4NS3 but not D3NS3
, (Table III-3 exp 2). CTLs from donor 3 had primarly serotye-specific responses to both
E and NS 1.2a but recognition ofNS3 was cross-reactive with D3NS3 and not D4NS3
(Table 11I-3 exp 2). The responses were serotype-specific for CTLs generated against
NS 1.2a (data not shown) and NS3 ( Table III-3 exp 2) from donor 4 PBMC. CTLs from
donor 5 were cross-reactive with both D2 and D4 NS3 (Table III-3 exp 2).
For donor 6 , the CTL response against the nonM protein was serotye-specific
(Table III-5 exp 1). Using target cells expressing NS3 ftom serotypes other than D4 for
donors 6 and 7 , CTLs were shown to be cross-reactive with D3NS3 for donor 6 and with
both 02 and D3NS3 for donor 7 (Table IIl-4 exp 2). CTLs from donor 8 were also cross-
reactive as target cells expressing DIE.NS1.2a were lysed (Table IlI-4 exp 2). These
results suggest that the CTL responses to nonstrctural proteins were predominantly
cross-reactive and the responses to strctural proteins were serotye-specific.
E. LOCALIZATION OF THE EPITOPE WITHIN THE NS3 PROTEIN RECOGNIZED
BY CTLs FROM DONORS 3 , 5 , 6 and 7.
Donor 3 PBMC recognized D2 and D3NS3 (Table IlI-3 exp 2 and Table IIl-6 exp
I) to similar levels. We used recombinant vaccinia viruses expressing truncated D3NS3
proteins to localize the epitopes on NS3 recognized by this donor s CTLs. The epitope
was localized to a region between a.a. 247 and 618 , since a truncated vaccinia
recombinant containing a. 247 (Vac D3-8) ofD3NS3 was not recognized (Table IIl-
exp 1). From exp 2 the area was fuher localized to the region from a.a. 247- 412 since
Vac D3-C2 (a.a. 412-618) was not recognized. Exp 3 narrows the epitope down to a
region between a.a. 247 and 354. Similarly, for donor 5 , it appears that the epitope lies
between a.a. 214 and 247 (Table IIl-6 exp 2 and 3 ).
TABLE 111-6 Localiation of the epitopes on NS3 recognized by CTLs generated
from PBMC of a dengue 2 immune donor 3 and a dengue 3-immune donor 5
% Specific Cr release
Target cells a. t Donor 3 Donor 5
inected with (D2) (D3)
Exp. Vac.D2 (NS3) 618
Vac.D3 (NS3) 618
V ac.D3- 247
Vac.D3- 214
Vac.D3- 176
Vac. (Control)
Exp. 2 Vac.D3 (NS3) 618
Vac.D3- 548
Vac.D3- 214
Vac.D3-C 1 447-618
Vac.D3- 412-618
Vac. (Control)
Exp. Vac.D3 (NS3) 618
Vac.D3- 354
Vac.D3- 247
Vac. (Control)
. PBMC were stimulated with autologous virus once in vitro and used as effectors.
Autologous target cells (10 ) were infected with DV NY recombinants and incubated
with effector cells for 4-5 hours. The effector/target ratio was approximately 100: 
t The numbers indicate amino acid residues ofNS3 expressed by the varous
recombinant VV'
From the results in Table ID-7 exp 1 , we conclude that CTLs from donor 6
recognzed an epitope between a.a. 1-183 ofNS3. The CTLs of donor 7, on the other
hand, recognzed a region between a.a. 453 and 618 on NS3. Using synthetic peptides we
confirmed that the recogntion was directed against a peptide containing a.a. 500-508 of
NS3 (Table ID-7 exp 2). Ths is in agreement with previous work in our laboratory,
which showed that CD8+ CTL clones isolated from this donor recognzed a synthetic
peptide containig a.a. 500-508 ofNS3. CTLs in bulk cultue were also shown to lyse
synthetic peptides contaig a.a. 500-508 ofD2 and D3NS3 , confirming the cross
reactive natue of this response at the peptide level (Table III-7 exp 2).
F. PHENOTYPE OF DENGUE-SPECIFIC CTLs IN BULK CULTURS.
To identify the phenotyes of dengue virus-specific cytotoxic T cells in each of
the donors, cell depletion studies with monoclonal antibodies and complement were
cared out. The assays were done 7-9 days after stimulation with autologous virus for
donors 2 , 7 and 8. For donors 1 and 6 effector cells were restimulated on day 7
and used on day 14. The effector cell populations were tested against target cells infected
with vaccinia recombinants expressing portions of the dengue genome that had elicited
signficant lysis in previous experients, a control vaccinia virus, and a natual killer
(N) cell-sensitive tuor cell line, K562. For donor 2 , autologous BLCLs persistently
infected with D2V were used as targets.
TABLE 111-7 Localiation of the epitope on NS3 recognized by PBMC of dengue 4-
immune donors 6 and 7
% Specific Cr release
Target cells infected or Donor 6 Donor 7
pulsed with (D4) (D4)
Exp. Vac.D4.NS3 618
Vac.D4 (1-452) 452
Vac. D4 (183-452) 183-452
Vac. D4 (453-618) 453-618
Vac. (Control)
Exp. Vac.D4 (453-618)
Vac. (Control)
Pep.D2. 500 500-508
Pep.D3.500 500-508
Pep.D4.500 500-508
None
. The number indicates amino acid regions on D4 NS3 expressed by the recombinant
vaccinia viruses. Peptides were present at a final concentration of 25/-g/ml for the
duration of the assay.
Treatment with anti-CD3 antibody and complement depleted the specific killing
activity (Table III-8). These results indicate that the killing was mediated by T cells in all
donors. For donor killing of target cells expressing the envelope and nonstrctual
proteins NS1.2a (infected with recombinant Vac DIE.NS1.2a) was mediated by CD4+
CTLs because depletion with anti-CD4 and complement decreased the killing
substantially. Killng of donor 1 targets infected with a constrct containing all three
strctual proteins (Vac DIC.prM.E) (Table 1II-8) was mediated by CD4+ and CD8+
CTLs since depletion with either anti-CD4 or anti-CD8 decreased killng.
For the other donors tested, killing was mediated almost exclusively by CD8+
CTLs as treatment with anti-CD8 and complement signficantly decreased the lytic
activity. No other antibody had a signficant effect on the levels oflysis for these donors.
Taken together the results suggest that stimulation of immune PBMC in vitro with
infectious dengue virus activated mainly CD8+ memory CTLs , and the levels of CD8+
CTL activity vared between donors.
, .
Table 111- Characterization of Cytotoxic T cells generated in bulk culture
TRATMENTS
DONOR TARGET CELLS Anti-CD3 Anti-CD4 Anti-CD8
Anti-CD 16 Phenotye
INECTED WIll +C' +C' +C' +C' of cells
Donor 1 Vac. D1 (E.NS1.2a) CD4
(D1)
Vac. D1 (C.prM. CD4 + CD8
Vac. (control)
K562
Donor 2 D2V inected
CD8
(D2)
Unifected
K562
Donor 3 Vac. D2 (NS1.2a) CD8
(D2)
Vac. D2 (NS3) CD8
V ac. (control)
K562
Donor 5 Vac. D3 (NS3) CD8
(D3)
V ac. (control)
K562
Donor 6 Vac. D4 (nonM) CD8
(D4)
V ac. (control)
K562
Donor 7 Vac. D4 (NS3)453.628
CD8
(D4)
Vac. D4 (E) CD8 + CD4
Vac. (control)
K562
Donor 8 Vac. D4 (NS1.2a) CD8
(D4)
Vac. (control)
K562
Values are % specific 51 Cr. release from target cells. Bulk cultues from donors 1 and 6
were restimulated and tested at 14 days whereas all other donors ' PBMC were tested at 7
days in CTL assays. Underlined values are those that were decreased by 2: 50% compared
to controls with the indicated treatment. The 
EfT ratio was between 100 and 150:1 before
treatments.
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G. HLA RESTRICTION OF THE LYSIS OF TARGET CELLS BY CD8+ BULK
CULTUR CTLs
HLA restrction of the CD8+ bulk cultues was examned in four immune donors
to identify the predomiant restrcting alleles in these cultues. Target cells were infected
with the recombinant vaccina viruses that had previously elicited signficant lysis or with
a control vaccina virus. From Table III- , we conclude that recogntion ofE, NS 1.2a and
NS3 by PBMC of donor 2 were all restrcted by HLA-B44, as only allogeneic target cells
having HLA-B44 in common with the autologous BLCLs showed significant lysis.
The nonstrctual protein NS3 was recognzed by CTL of a majority of our
donors, therefore we tested the HLA restrction of thee additional donors that had NS3-
specific CTLs. The results indicate that recogntion ofNS3 by donor 3 CTL was B38
restrcted. For donor 5 , it appears that either A24 or B62 (or both) may restrct
recogntion ofD3NS3. In bulk cultue, CD8+ CTLs from donor 7 lysed allogeneic
targets pulsed with a. 500-508 that have only HLA B35 in common with autologous
targets, confirming what we observed earlier with CD8+ CTL clones of this donor.
CHAPTER IV
ANALYSIS OF DENGUE VIRUS-SPECIFIC CTL RESPONSES AFTER
NATURA SECONDARY DENGUE INFECTIONS
A. PROTEIN SPECIFICITY OF CTLs IN BULK CULTUR
To detect dengue virus-specific CTL, we stimulated immune PBMC (12 months
after infection) with a homologous dengue virus (i.e. the same serotype of virus as the
patient's isolate) and tested for cytolytic activity in bulk culture against the homologous
dengue virus proteins. We detected CTL activity in bulk culture PBMC from patient
KPP94-037 against target cells infected with vaccinia recombinants expressing the
nonstructural proteins D2NS 1.2a primarily and to those infected with Vac. D2NS3 to a
lesser degree (Table IV- I). For patients KPP94-024 and CHD94-020 , the predominant
CTL response was directed against the homologous NS3 protein (Table IV - 1). Even
though the level oflysis of wild type vaccinia virus-infected target cells was high for
patient KPP94-024, there was substantial killing against targets expressing D2NS3. For
patient CHD94- 134 low level CTL activity was detected in bulk culture against all the
dengue vaccinia recombinants tested. These results show that, in bulk culture
experiments , PBMC from all four of the patients had detectable cytolytic activity against
target cells expressing non structural proteins NS l.2a or NS3.
Table IV-I: Bulk Culture CTL ofPBMC obtained from children 1 year after
natural infection with dengue virus
Target cells Percent dengue specific 51 Cr. release
infected with
KPP94-037 KPP94-024 CHD94-020 CHD94- 134
Vac. D2CprME
Vac. D2NS 1.
Vac. D2NS3
Vac. D4CprME 
V ac. D4NS 1.2a
V ac. D4NS3
PBMC (1-3xl0 ) were stimulated in vitro with the homologous serotye of dengue virus
(dengue-2 for KPP94-037 , KPP94-024 and CHD94- 134 and dengue 4 for CHD94-020).
Cells were restimulated with anti CD3 and allogeneic feeders on day 7 and then every
two weeks. The cells were used as effectors and tested in CTL assays on days 14 to 35 
cultue. % specific lysis represents lysis oftarget cells infected with recombinant
vac/dengue viruses - lysis of target cells infected with control vaccinia virus. The vaccinia
control values for KPP94-037 was 6%, KPP94-024 - 51 %, CHD94-020 - 29% and
CHD94-134 - 33%. Effector to target ratios were 70:1 for KPP94-037 and 50:1 for other
donors
B. SEROTYPE CROSSREACTIVITY OF T CELL LINS ESTABLISHED FROM
PBMC OF PATIENTS KPP94-037 AN KPP94-024
T cell lines were established by limiting dilution from the bulk cultues obtained
from patients KPP94-037 and KPP94-024. For patient KPP94-037 , the lines were
initially screened using Vac. control, Vac D2NS3 and Vac D2NS l.2a. All lines that had
dengue-specific lytic activity were found to recognzethe nonstrctual proteins NS1.2a
(data not shown). Among 12 T cell lines, 4 lines had the CD3+CD4+CD8- phenotye and
8 lines had the CD3+CD4-CD8+ phenotye (Table IV -2). These NS 1.2a specific CTL
lines were tested for crossreactivity against Vac.DIENS1.2a and Vac.D4NS1.2a
constrcts. Recogntion ofNS1.2a by all the T cell lines was crossreactive against dengue
, dengue 2 and dengue 4 (Table IV-2).
For patient KPP94-024, 12 NS3 specific T cell lines were isolated after initial
screening against target cells inected with Vac.control and V ac.D2NS3 (data not shown).
These T cell lines were then tested for crossreactivity to other dengue serotyes (Table
IV-3). All of the CTL lines were crossreactive against dengue 3 and dengue 4. These
results indicate that all the dengue virus-specific T cell lines established from patient
KPP94-037 were serotye crossreactive and recognzed the NS 1.2a proteins, and that
those established from PBMC of patient KPP94-024 were also serotye crossreactive but
recognzed the NS3 protein. The protein specificities of T cell lines isolated from 
donors.
, ..
Table IV-2: Serotype crossreactivity ofT cell lines generated from PBMC of
patient KPP94-037 1 year after secondary D2V infection.
Cell Phenotype Percent specific Cr. release
Line
Vac. Vac. Vac. Vac.
control DIENS1.2a D2NS 1. D4NSl.
2G3 CD4+
2E8 CD4+
2Dll CD4+
2B5 CD4+
3Cll CD8+
3E7 CD8+ 100
3F3 CD8+ 100
2C8 CD8+
2G7 CD8+
2D9 CD8+
3Fll CD8+
3GlO CD8+
T cell lines were established from bulk cultue ofPBMC from patient KPP94-037 by the
limiting dilution method. The phenotye of the cells was determned by fluorescent
antibody staing. Percent specific Cr. release of indicated target cells was measured at
EfT ratios between 20:1 and 60:1 for all the lines used.
\ \
Table IV-3: Serotype crossreactivity of CTL lines generated from PBMC
of patient KPP94-024 1 year after secondary D2V infection
Cell Phenotye Percent specific Cr. release
Line
Vac. Vac Vac Vac.
control D2NS3 D3NS3 D4NS3
2B2 CD4+
2Dll CD4+
2C9 CD4+
3E5 CD4+
2Bll CD4+
2E3 CD8+
3C3 CD8+
3Bll CD8+
2GlO CD8+
2C8 CD8+
3C2 CD8+
2F5 CD8+
T cell lines were established from bulk cultue ofPBMC from patient KPP94-024 by the
limiting dilution method. The phenotye of the cells was determined by fluorescent
antibody staing. Percent specific Cr. release of indicated target cells was measured at
EfT ratios between 20: 1 and 60: 1 for all the lines used.
KPP94-037 and KPP94-024 were consistent with those of the bulk cultue CTLs ftom the
same subjects, shown in table IV- I C.
HLA RESTRICTION OF THE LYSIS OF TARGET CELLS BY CD8+ AN CD4+
CTL LINS FROM PBMC OF PATIENTS KPP94-037 AN KPP94-024
For patient KPP94-037, allogeneic BLCLs which had HLA alleles in common
with autologous cells were infected with Vac. D2NS l.2a and used as targets. Experiment
1 in Table IV -4 shows that thee representative CD8+ lines were also HLA B57 restrcted
because only targets having B57 in common with the autologous BLCLs were lysed
effciently by CD8+ CTLs. Other CD8+ lines established from patient KPP94-037 were
B57 restrcted. Experiments 2 and 3 , using allogeneic BLCLs that had Class II alleles in
common with the autologous line, indicate that 2 of the CD4+ CTL lines from patient
KPP94-037 were HLA DR7 restrcted.
For patient KPP94-024, allogeneic BLCLs sharng Class I alleles with autologous
BLCLs were infected with recombinant vaccinia expressing D2NS3. Four representative
CD8+ lines generated ftom patient KPP94-024 were HLA B7 restrcted (exp. 1 and 2
Table IV -5). Other CD8+CTL lines established from patient KPP94-024 were also B7
restrcted (data not shown).
Table IV -4: HLA restriction of recognition of dengue viral proteins by
CTL lines from patient KPP94-037
% specific Cr.
release
T cell lines 
Experiment 1 HLA CLASS I 3E7 2E4 2C8
Autologous 11.1 B46
HCV57 A2.
9052 B27
GM3098A B 57
Experiment 2 HLA CLASS II 2D11 2G3
Autologous DP5 DQ9 DR7
9077 DP5 DQ3 DR9
DP4 DQ2 DR5
Experient 3 Autologous DP5 DQ9 DR7
KPP94-024 DP5 DQ9 DR9
CHD94- 134 DP4 DQ9 DR7
DQ1 DR1,4
BLCLs were infected with vaccina recombinants expressing D2NS 1.2a. Allogeneic
targets that shared one or more HLA Class I alleles with the autologous line were used in
Experiment 1 and those that had HLA Class II alleles in common with the autologous line
were used in Experients 2 and 3. The EfT ratios were between 16:1 and 40:1 for all the
T cell lines used.
Table IV -5: HLA restriction of recognition of dengue viral proteins by CTL lines
from patient KPP94-024
% specific Cr.
release
T cell lines 
Experient HLA CLASS I 2F5 2C8
Autologous
VA03
9077 B46 Cll
B51
Experiment 2 HLA CLASS 2F5 3C2 3Bll
Autologous
TomG A23 29 B7
GM3161
GM6825A A23
BLCLs were inected with vaccina recombinants expressing D2NS3. Allogeneic targets
that shared one or more HLA Class I alleles with the autologous line were used in
Experiments 1 and 2. The EIT ratios were between 16: 1 and 40: 1 for all the T cell lines
used
D. SEROTYPE CROSSREACTIVITY, HLA RESTRICTION AN EPITOPE
ANALYSIS OF BULK CULTUR CTL GENERATED FROM PBMC OF PATIENT
CHD94-020.
For patient CHD94-020, bulk cultue CTLs lysed targets expressing the NS3
proteins ofD2, D3 and D4 virs (Table IV- I and IV -6). Using recombinant vaccinia
viruses expressing trcated D3NS3, we were able to localize a CTL epitope to a.a 1- 176
ofNS3 (Table IV-6 expo 2). Using allogeneic targets having HLA class I alleles in
common with CHD94-020 , bulk cultue CTL activity was found to be HLA-Al1.
restrcted, based on recogntion of CHD94- 134 BLCL target cells, which share only
Al1.1 in common with the autologous line (Table IV-6 exp 3). These results indicate that
the NS3 specific CTLs detected in bulk cultue from this subject are Al1. 1 restrcted and
are also serotye crossreactive. We tred to isolate CTL lines from this donor by the
limiting dilution method but were not successful.
E. LOCALIZATION OF THE EPITOPE WITHIN THE NS3 PROTEIN RECOGNIED
BY T CELL LINS FROM PBMC OF PATIENT KPP94-024.
CTL lines from patient KPP94-024 lysed target cells expressing NS3; therefore
we infected target cells with vaccina recombinants expressing trcations ofthe D3NS3
gene to localize the epitopes recognzed by these CTL lines.
TABLE IV-6: Serotype cross reactivity, Epitope localiation and HLA Restriction of
Bulk Culture CTL obtained from PBMC of Patient CHD94-020.
Target cells HLA CLASS I % specific
infected with ALLELES 51 Cr release
Experient 1
Vac. control
Vac. D2C.prM.
Vac. D2NS 1.
Vac. D2NS3
Experiment 2
Vac. control
Vac. D3NS3
Vac D3 (1- 176)
Experient 3
Autologous 11.1
KPP94-024
KPP94-037 11.1
CHD94- 134 11.1 28 27
PBMC from patient CHD94-020 were stimulated with D4 virus and 7 days later
restimulated with anti-CD3 and allogeneic feeders. Cells were restimulated every two
weeks and tested in CTL assays 7-10 days after the last restimulation. The EfT ratio
was 50:1 for exp.'s 1 and 2 and 106:1 for expo 
Table IV-7: Localization of the epitope on NS3 recognized by CTL lines of patient 
KPP94-024
Target cells infected or % specific 51 Cr. release
pulsed with
T cell lines 
2GI0 2F5 3C2 3C3 2E4 3E5 3B11 2C9
Experient 1
V ac. control
Vac. D3NS3
Vac. D3NS3 (a.a 1-133)
Vac. D3NS3 (a.a 1-176)
Vac. D3NS3 (a.a 1-216)
Vac. D3NS3 (a.a 1-247)
Experiment 2
No peptide
D4NS3 221 (a.a 221-235)
D4NS3221a (a.a 224-235)
D4NS3 221c (a.a 226-
235)
D4NS3 221d (a a 227-
235)
D4NS3 22lf(a.a 221-233)
D4NS3 221g (a.a 221-
232)
Experiment 3
No peptide
D4NS3 221 (a.a 221-235)
D4NS3 221g (a.a 221-
232)
D4NS3 222z (a.a 222-
230)
Exp. 1 BLCLs were infected with vaccinia recombinants expressing different trcations
of the NS3protein as indicated and used as target cells. Exp 2 & 3. BLCLs were pulsed
with 25/lg/ml of the indicated peptide for 30 mis. after which the T cells were added and
fuher incubated for 4- 5 hours. The EfT ratios were between 10:1 and 60:1 for all of the 
T cell lines used in these assays.
We mapped the region on the NS3 protein recognzed by all T cell lines tested
from patient KPP94-024 to a.a 216-247 ofNS3 (Table IV- , exp 1). We then tested for
CTL activity against overlapping peptides which spaned that region and found lytic
activity only against peptide 221 , which is a 15mer corresponding to a.a 221-235
(LAPTRVV AAMEEAL) (data not shown).
We used synthetic peptides with trcations of peptide 221 to detect the minimum
epitope recognzed by the T cell lines (Table IV- , exp 2 and 3). Peptide targets pulsed
with trcations 221g and 22lfwere lysed by most CTL whereas target cells pulsed with
trcations 221a, 221c and 221d were not lysed. T cell lines 2F5 and 3C3 recognze a.
222-230 ofNS3 and most of the other T cell lines recognze targets that were pulsed with
a. 221-232 ofNS3.
.. .
CHAPTER V
ANALYSIS OF IN VITRO PROLIFERATIVE RESPONSES OF ACUTE AND
IMMUNE PBMC FROM THAILAND
A. PBMC FROM CHILDREN WITH ACUTE DENGUE INECTION HAVE
DECREASED L YMPHOPROLIFERATIVE RESPONSES TO PHA
, DENGUE
ANTIGENS AND RECALL ANTIGENS.
We analyzed the proliferative responses of acute and immune PBMC ftom
patients with varying grades of severity of dengue illness to mitogens and other antigens.
Acute PBMC samples obtained from patients at different time points after they were
admitted into the study (study day 1 up to study day 11) were tested in this assay (Table
II-4). The responses during acute infection were compared to the proliferation of the same
patients ' PBMC obtained 6- 24 months after their acute infection. In all 14 patients there
was a significant decrease in proliferation of acute PBMC in response to stimulation with
PHA (Figure V- I). In the 4 patients tested there was a decrease in the response to dengue
antigen and also to a recall antigen, tetanus toxoid, in the acute samples of PBMC (Table
I). Background cpm of acute PBMC were consistently lower in all patients compared
to their immune PBMC but the stimulation indices still indicated a substantial decrease in
proliferation of acute PBMC compared to that of
Figure V- PBMC from patients with acute dengue infection do not respond
in vitro to mitogen stimulation.
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1 x 1 0 5 acute and immune PBMC from patients were stimulated with a 1: 1 000 dilution of
PHA. Patient numbers are given along the vertical axis with acute sample numbers (A
study day) in parenthesis. All immune bleeds were obtained at one year or later after
infection except for #13 which was obtained at 6 months. For patients #9 and #11 , a two
year bleed was used in this assay as the immune sample. Cells were pulsed with 3HTdR
for 18 hours and harested 5 days after incubation at C. The data presented are from
the 9 different experiments which were performed.
Table V- PBMC obtained during acute dengue infection do not respond to
dengue antigens and recall antigens in proliferation assays 
PATIENT STUDY DAY Dengue antigen Tetanus Toxoid No antigen
NUBER
(AI) 141 140 128
(13 3 6) 14166 45391 387
(A3)
(1367) 2939 5090 227
(A4)
(1372) 2094 1370 169
(A5)
(1366) 2344 5376 856
a 1 x 1 0 PBMC from acute (A) and immune (I) phases of infection from the same patient
were stimulated with a 1 :40 dilution of dengue antigen or a 1 :5000 dilution of tetanus
toxoid and incubated for 6 days in a 96 well plate at 37 C. Cells were pulsed with 3HTdR
on day 6 for 18 hours and harvested. The results presented are from 4 different
experiments performed. Data are mean cpm of2 or 3 replicates
immune PBMC (Table V- I and data not shown). The results indicate that in vitro
proliferative responses of PBMC to mitogens and specific antigens are suppressed in all
grades of acute dengue infection. Samples tested up to 11 days after the patient was
admitted into the study showed decreased responses compared to the same individuals
immune samples.
B. RECOMBINANT IL- AN IRRIATED PBMC RESTORE PROLIFERATION
OF ACUTE PBMC
To characterize the immunological unresponsiveness of the acute PBMC , we
treated the PHA-stimulated cells with 10U/ml of recombinant IL-2. Inadequate
production ofIL-2 by T cells is thought to be one of the factors that contribute to the
immunosuppression seen during acute measles and CMV infection. In 8 of 9 patients
tested, the in vitro proliferative responses to PHA were restored by the addition 
exogenous IL-2 (Table V -2). PBMC samples tested from study day 1 , when the patients
were sick and had severe symptoms, also responded to IL-2. In one patient (#12),
addition of up to 100U/ml of IL-2 did not restore proliferation (data not shown).
Table V-2 Decreased proliferative responses of acute PBMC are
partially restored upon the addition of IL-2 or gamma-irradiated
autologous or allogeneic PBMC 
PHA PHA + IL- PHA + irradiated PBMC
Autologous Allogeneic
2(Al)b 308 62514
3(A3) 899 23637 23146
5 (A9) 4600 73073 22886
7(A3) 627 17593 59555
9(Al) 1049 26314
1O(A9) 3240 71969
12(A2) 102 128
13(All) 3917 54815 130788
16(A9) 1396 64821
1OU/ml ofrecombinant IL-2 or lx10 gamma irradiated autologous
immune (for patients 5 7 and 13) or allogeneic healthy PBMC
(for patient 3) were added to acute PBMC stimulated with a
1: 1000 dilution of PHA and incubated for 5 days. Cells were pulsed
overnight on day 4 with 3HTdR and harvested. The results presented are
from 8 different experiments performed. Data are mean cpm of 2 or 3
replicates.
b Acute sample numbers are indicated in parenthesis
ND = not done.
Addition of lxl0 gamma-irradiated, autologous immune or allogeneic control PBMC
also improved proliferative responses of acute PBMC (Table V -2). Our data show that the
unresponsive acute PBMC can be induced to proliferate by the addition of the cytokine
IL-2 or irradiated control PBMC. However, these results do not indicate if released
soluble factors or cell contact with the irradiated PBMC are essential to restore the
proliferation of the acute PBMC.
C. ACUTE PBMC REQUIRE CELL CONTACT WITH GAMMA-IRRIATED
CONTROL PBMC TO INCREASE PROLIFERATIVE RESPONSES
To determine if cell contact with the irradiated PBMC is needed to mediate
proliferation , we used a transwell system in which acute cells were separated from
allogeneic control PBMC by a polycarbonate membrane. When acute and gamma-
irradiated allogeneic cells were incubated together in the upper well , there was a
substantial increase in proliferation compared to acute T cells alone stimulated with PHA
(Figure V-2). When gamma-irradiated PBMC were separated from the acute cells in the
upper well by a polycarbonate membrane, proliferation was much lower in all 4 patients
PBMC compared to when the cells were incubated together. In patient 6 , acute cells
proliferated somewhat when they were separated from the gamma-irradiated control cells
by the membrane (approximately 30 000 cpm compared to 135 000 cpm) suggesting that
Figure V -2 Acute PBMC from patients with dengue viral infection require contact
with control PBMC to increase proliferative responses.
160000
140000
120000
100000
80000
60000
40000
20000
Upper
o Acute PBMC
rn Acute + g. allo. PBMC
. Acute PBMC
Lower
Media + PHA
Media + PHA
g. allo. PBMC + PHA
1 x 1 0 acute PBMC were added to the upper well of the transwell. 6x 1 0 gama
irradiated allogeneic PBMC were added to the upper or lower well ofthe transwell as
indicated. Cpm of the irradiated allogeneic PBMC incubated with PHA was less than
1148 cpm. Patient numbers are given along the X axis and sample numbers of the acute
bleeds are given in parenthesis. The results presented are from two different experiments
performed.
Patient (acute sample)
, .
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both soluble factors and cell contact were important in restoring proliferation. However
these results suggest that cell contact with gama-irradiated allogeneic PBMC is
predominantly required to restore proliferation of acute cells.
D. ACCESSORY CELLS IN PBMC OBTAID DURG ACUTE DENGUE
ILLNESS AR UNABLE TO PROVIDE ADEQUATE STIMI TO INUCE
PROLIFERATION OF T CELLS
To fuer demonstrate that there is a defect in the accessory cells in the acute
PBMC samples, both T and non- T cells were isolated from patients with acute dengue
and mixed in proliferation assays with T and non-T cells from a control donor. When T
cells from a control donor were added to gama-irradiated non- T cells from the acute
PBMC , responses were substantially reduced, indicating that the non- T cells in the acute
PBMC sample could not support the proliferation of T cells from a control donor (Table
3). In contrast, when T cells from an acute dengue patient were mixed with non-T cells
from a control donor, substantial proliferation was observed. The results indicate that the
T cells in the acute PBMC samples from dengue patients are able to respond when
optimal stimuli from the PBMC of a control donor are provided.
rt'
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Table V-3 Non T cells from acute PBMC of patients with dengue cannot
support the proliferation of healthy T cells
Patient (acute sample)
10(A9) 13 (All) 15 (A2)
T (acute PBMC) + Y nonT (acute PBMC) + PHA 308 199
T (acute PBMC) + Y nonT (healthy PBMC) + PHA 15302 16661 12693
T (healthy PBMC) + Y nonT ( healthy PBMC) + PHA 21671 5028 7471
T (healthy PBMC) + Y nonT (acute PBMC) + PHA 1420 3534 736
y nonT (healthy PBMC) + PHA 727 339 911
y nonT (acute PBMC) + PHA 116
Acute PBMC + PHA 409 616
Healthy. PBMC + PHA 45830 45830 25671
T cells were isolated from acute PBMC of patients with dengue infection or healthy
control PBMC and mixed with non T cells from either healthy or acute PBMC. For
patient 10 26000 T cells and 110 000 non T cells were added per well, for patient 13
22000 T cells and 70 000 nonT cells were added per well and for patient 15 , 12000 T
cells and 33000 nonT cells were added per well. Cells were incubated at 37 C for 5 days
pulsed and then harested. The results presented are from two different experiments
performed.
. .
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E. CD28 ANilODIES INCREASE PROLIFERATION OF ACUTE PBMC IN
CERTAI PATIENTS WITH ACUTE DENGUE ILLNESS
To analyze whether co stimulatory molecules may playa role in the cell-mediated
suppression of acute PBMC samples, we treated the PBMC of6 subjects with anti-CD28
and anti-CD3 antibodies. In three patients (#6, #13 and #15), addition ofanti-CD28
restored proliferation of acute PBMC to levels comparable to stimulation with anti-CD3
+ IL-2 (Figue V-3). The PBMC samples from these patients were obtained at least 8
days after enrollment, at which time the subjects were no longer febrile or viremic.
PBMC from thee other patients (#3 , #7 and #17) did not respond to co stimulation with
either 5 or 1 0 g of anti-CD28. The PBMC were obtained from these patients when they
had the most severe symptoms (days 2 or 3 after they were enrolled into the study) and
were acutely ill in the hospital. Study days 2 or 3 also represent days when the absolute
monocyte counts drop to the lowest levels. The results suggest that anti -CD28 antibodies
can restore proliferation of PBMC samples when the patients are recoverig from illness
but have no effect on PBMC obtaied from the patients at the peak of their illness.
:i'
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Figure V -3 Anti-CD28 antibodies increase proliferation of anti-CD3 stimulated
acute PBMC obtained at later time points during acute infection'
30000
25000
20000
15000
10000
5000
(' .. 
Patient (acute sample)
mCD3
. No Ag.
EI CD3 + CD28
II CD3 + IL-
lxl0 acute PBMC were stimulated with 0. 1 Ilg/ml of anti-CD3 antibodies, anti-CD3 +
anti-CD28 (10Ilg/ml) or anti-CD3 + IL-2(lOU/ml) for 5 days. Cells were pulsed
overnght and harested. Patient numbers are given along the X axis with acute sample
numbers in parenthesis. The results presented are from 4 different experiments
performed. PBMC from patients 7 and 17 were not tested for stimulation with CD3+IL-
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F. ACUTE PBMC SAMLES HAVE DECREASED NUERS OF MONOCYTES
BUT NORM PERCENTAGES OF T AN B CELLS
We found a decrease in the number and percentage of monocytes in the acute
PBMC samples compared to the convalescent samples (Table V -4). However, there was
no decrease in the percentage of either CD4 or CD8 T cells in the acute PBMC.
Therefore, a reduction in the number of T cells canot be the primar reason for
inadequate proliferative responses. There was also no difference in the percentage ofB
cells durng acute infection.
G. IL- AN IL- , BUT NOT IL-4 OR IL- , IMROVE PROLIFERATION OF
PBMC OBTAID DURG ACUTE DENGUE INECTION
Since receptors for the cytokines IL- , IL- , IL-7 and IL- 15 are known to share a
common gama chain, we examined whether cytokines other than IL-2 would also help
overcome the unesponsiveness ofthe acute phase PBMC. We chose IL- 12 as a cytokine
that did not utilize the common gama chain. In 4 of 4 patients tested, the acute PBMC
samples responded to anti-CD3 in the presence ofIL-2 or IL-7 but not in the presence of
IL- , even at a concentration of 500U/ml (Figue V -4 and data not shown). No increase
in proliferative responses to anti-CD3 was detected in the presence ofIL- 12. The results
indicate that several but not all, cytokines whose receptors share the common gama
. chain are able to restoreJhe proliferation of the PBMC obtained durng acute infection.
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Table V -4 Percentages of T cells, B cells and monocytes in acute and convalescent
PBMC populations. 
PATIENT SAMLE % T CELLS % B CELLS
NUER CD4 CD8 MONOCYTES
C354
C725
All
C196
a Cryopreserved PBMC from acute and convalescent samples from each patient were
thawed and stained with FITC conjugated antibodies to CD4, CD8 , CD 14 and CD 19 and
analyzed by flow cytometr.
4' '
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Figure V-4 Acute PBMC respond to CD3 + IL-7 stimulation but not IL-4 or IL-
stimulation
12000
10000
8000
6000
4000
2000
8CD3
o CD3 + IL-
II CD3 + IL-4
lI CD3 + IL-
. CD3 + IL-
Patient (acute sample)
lxl0s cells were stimulated with 0. 1 flg/ml of anti CD3 antibodies and either 10U/ml
IL- , 100U/ml IL- , 100U/ml IL-7 or 25 ng/ml IL-12. Cells were pulsed with 3 TdR on
day 4 overnght and harested on day 5. The results presented are from two different
experiments performed. Patient numbers are given along the X axis with acute sample
numbers in parenthesis.
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CHAPTER VI
DISCUSSION
A. CD8+ CTL RESPONSES IN V ACCIN RECIPIENTS
Our aim in this study was to analyze the diversity of bulk cultue CD8+ CTL
responses in volunteers who received candidate monovalent live attenuated dengue
vaccines ( Dl, D2, D3 or D4 ).The data generated would complement existing
information on CD4+ CTL responses to dengue infection.
I fist examined the proliferative responses ofPBMC from all donors to varing
concentrations of live flavivirses. Most of the studies that had been done prior to the
outset of the project had examined dengue-specific T cell responses following stimulation
with noninfectious dengue antigen. The PBMC of all subjects exhibited proliferative
responses with the most signficant proliferation to the serotype of virus contained in the
vaccine that they had received and a varable level of cross reactive proliferation to other
dengue serotyes or to other flaviviruses. The results demonstrated that dengue virus-
specific memory T cells were generated after priar immunzation and the patterns of
specificities of these T cell responses vared.
We also detected dengue-specific CTL activity in all 8 donors , indicating that
these live-attenuated vaccines elicited dengue-specific CTL responses. We found CTL
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killing against a wide varety of proteins including the envelope (E), premembrane (prM)
and nonstrctual proteins (NS l.2a and NS3) of dengue virses as sumarzed in Table
VI- I. Seven of eight donors had CD8+ CTL responses diected against one or more of
these proteins, although the levels of lysis vared between donors.
In initial studies of dengue virus-imunzed inbred mice, bulk cultue CD8+
CTLs recognzed only a very limited number of epitopes on dengue virus proteins - as
few as one to three on the entire genome, which encodes 3 386 amino acids (Rothman, et
aI. , 1993). CTLs from H- mice recognzed an epitope on the NS3 protein. CTLs from
mice recognzed an epitope on the NS4a or NS4b proteins. CD8+ CTLs generated
from H- mice recognzed an epitope on a strctual protein, the NS 1 or NS2a and the
NS3 proteins. In humans, CD8+ CTL clones were established from only one donor
Donor 7, which recognzed a.a 500-508 on the nonstrctual protein NS3 (Livingston, et
aI. , 1995). This preliminar study suggested that there were a limited number of CD8+
CTL epitopes on dengue proteins in humans as well.
The results generated from the study done in Chapter III illustrate that there are
multiple CD8+ CTL epitopes on both strctual and nonstrctual proteins , which is
similar to our previous results demonstrating that multiple epitopes were recognized by
dengue virus-specific CD4+ CTLs in both humans and mice (Gagnon, et aI. , 1996, Green
et aI. , 1993 , Kurane, et aI. , 1991b, Kurane, et aI. , 1989b , Zeng, et aI. , 1996, Zivny, et aI.
1993). T cell clonig experiments on the PBMC from different volunteers is likely to
'.':
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generate numerous CD8+ CTL clones consistent with the bulk cultue results.
1. Immunodominance of nonstrctual proteins as CTL targets
All donors had CTLs that recognzed at least one nonstrctual protein (NS3 or
NS1.2a) (Table VI- I). The predominant protein that was recognzed by the PBMC of
the 8 donors was the nonstrctual protein NS3. NS3 is the second largest viral protein
(containng 618 amino acids) and is one of the most highly conserved proteins among
flaviviruses. Table VI-2 shows the serotye specificities of the bulk cultue CTL
responses to the different dengue proteins in these 8 donors. The results from Tables VI-
and 2 indicate that CTLs recognzing NS3 are usually cross reactive whereas CTLs
recognzing other proteins (E, prM and NS 1.2a ) are maily serotye specific. The cross
reactive natue of CTLs against NS3 may be due to the high levels of amino acid
conservation among the NS3 proteins of the different serotypes.
NS3 has both a protease (N terminus) and a nucleotide trphosphataselhelicase (C
terminus) activity. At the outset of this project, our laboratory had previously identified
multiple sites on NS3 recognzed by human CD4+ CTLs and one site recognzed by
CD8+ CTLs as shown in Figue VI-2. Here we show that there are at least four sites on
NS3 recognzed by CD8+ CTLs. Therefore, although there is a predominance of
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Table VI-2 Summary of serotype specific and crossreactive CTL responses to
dengue virus proteins in 8 vaccine recipients.
PROTEIN(S) # of DONORS # OF DONORS # OF DONORS
WITH CTL WITH WITH SEROTYPE
RESPONSE TO SEROTYPE CROSSREACTIVE
PROTEIN SPECIFIC RESPONSES
RESPONSES
NS3
NS l.2a
prM
C.prM.
\ .
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recogntion of determinants on the NS3 protein, there is no single immunodominant
epitope.
In the murne system we have shown that the nonstrctual protein NS3 is the
major target for dengue virus-specific H-2 k CTL (Rothman, et aI. , 1993). Other
laboratories have also found immunodominant murne CTL determants on
nonstrctual proteins of other flaviviruses. The Muray Valley Encephalitis (ME) NS3
protein has been shown to be a dominant source ofH- restrcted antigenic determinants
recognzed by MVE and WN-immune CTLs (Lobigs , et aI. , 1994). Using Kunjun and
WN to identify determnants for CTLs in mice of five H-2 haplotyes, the nonstrctural
proteins were shown to have the strongest response (Hill, et aI. , 1992, Parsh, et aI.
1991). For mice with the H- haplotye, a 98 amino acid fragment spanng the junction
between NS3 and NS4a ofKunjun virus was shown to be an immunodominant region.
Nonstrctual proteins from viruses belonging to other families such as the bluetongue
virus (Reoviridae), MCMV and HSV have also been shown to be an immunodominant
source of pep tides for CTL recogntion (Bans, et aI. , 1991 , Del Val, et aI., 1991 , Jones
et aI. , 1996). The €4ata 1:pport th bY130thcsis that pmtcins 'Nith an intacellular location
are a majQr souree ofT cell detGmnans.
The flavivirus genome encodes for a single polyprotein that gets co- and
posttanslationally cleaved to the individual proteins. The strctual proteins (C, prM,E),
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NSI and the N terminus ofNS2a are translocated into the lumen of the endoplasmic
reticulum via a series of signal and stop-transfer sequences as shown in Figure VI-
(Coia, et aI. , 1988 , Rice, et aI. , 1986). On the other hand, the NS3 and NS5 proteins
which are the largest proteins encoded by the dengue genome, have a cytoplasmic
localization. NS3 constitutes approximately 25% ofthe cytoplasmic region ofthe viral
polyprotein. This may be one of the reasons why NS3 is an immunodominant protein.
Since we have not tested vaccinia recombinants expressing NS5 , it is possible that there
are also T cell epitopes on NS5.
Viral polyprotein processing may not be a major factor influencing the
immunodominance ofNS3 , since in most of the studies cited vaccinia virus recombinants
expressing individual flaviviral proteins were used to infect target cells. Also, when a
large polyprotein fragment that was not correctly folded was used in the MVE studies, it
effciently sensitized taget cells for lysis (Lobigs, et aI. , 1994). Numerous other factors
such as the effciency of transport and peptide stability are likely to influence why
peptides ftom nonstrctual proteins are preferentially presented on MHC molecules
(Barber and Parham, 1994).
Since NS3 is recognized by a wide varety of CTLs from dengue-immune donors
and antibodies to NS3 are unable to mediate antibody-dependent enhancement of
infection, this protein is an attractive candidate for inclusion in a subunit vaccine.
However, it is also possible that NS3 specific CTL may contribute to the
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immunopathology ofDHF, as they can be reactivated following exposure to a
heterologous serotye of virus.
2. ero e s ecifici of T cell clones and bulk cultures
The demonstration that dengue virs-specific memory CTLs are serotye cross-
reactive after a priar dengue infection supports the possibility that these memory T
cells can be activated in secondar infections with a heterologous serotye of virus. 
have previously isolated human CD4+ CTL clones from different donors with varng
patterns of virs specificities (Figue VI-2). These include: dengue virus tye specific
clones, dengue virus subcomplex specific clones, dengue virus serotye-crossreactive
clones and flavivirus-crossreactive clones that recognze WN and/or YFV. The CD8+
CTL clones isolated from Donor 7 had thee patterns of serotye specificity, including
serotye-specific clones , dengue virus subcomplex-specific and serotye crossreactive
clones (Livingston, et aI. , 1995). These T cells may play important roles in recovery from
infection by other flaviviruses or in imunopathology.
The results from this curent study on 8 vaccine donors extend the observation
that human CD8+bulk cultures also have multiple specificities. We detected only
serotype-specific CTLs from 2 of8 donors (donors 1 and 4, Table VI- I). In the other
donors, we detected CTLs with varous patterns of serotye-crossreactivity, including
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recogntion ofD2 and D4 NS3 (donor 2), D2 and D3NS3 (donor 3), D3 and D4NS3
(donor 6), D2 , D3 and D4 (donors 5 and 7) and D ENS l.2a and D2NS l.2a (donor 8).
Data from these experiments fuer lend support to the possibility that both CD4+ and
CD8+ CTLs are capable of being activated in secondar infections with a different
serotye of virus and may contrbute to the pathogenesis seen in DHF.
3. HLA restrction and den e infection
Genetic factors may also playa critical role in accounting for the differences
between individuals in susceptibility to severe dengue infection. Since NS3 was the
immunodominant protein recognzed by CTLs, we examined the MHC restriction of
NS3-specific CTLs generated in bulk cultues ofPBMC from 4 donors to identify class I
alleles that might present different portions of the NS3 genome. For donors 2 5 and 7
the potential restrcting alleles for NS3-specific CTL are B44 , B38 , A24 &/or B62 , and
B35 , respectively.
It is interesting that for donor 2 , three CD8+ T cell epitopes on dengue viral
proteins (E, NS3 and NS1.2a) were recognzed in the context ofHLA-B44. A peptide
binding motif has been identified for HLA-B44 with an acidic amino acid (glutamic acid)
at P2 and a less rigid requirement for a basic or hydrophobic amino acid at P9 (DiBrino
et aI. , 1995). It is likely that if we were to identify nonamer peptides with the above motif
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. in the three proteins , one or more of them would be able to sensitize target cells for lysis.
Using the HLA-B44 motif, three different antigenic peptides from both influenza NSI
and NP proteins were shown to be presented by HLA-
B44 to antiinfuenza tye A-
specific CTLs from one donor (DiBrino, et aI., 1995). In an earlier study of Thai children
who had been hospitalized with severe dengue infection, HLA A2 and HLA B 
blan
appeared to be statistically associated with severe disease (Chiewslip, et aI.
, 1981).
The studies performed in Chapter il 
strengthen the information that exists on the
human T cell responses to dengue infection and show that
, in bulk cultue, CD8+ CTL
responses can be generated against several proteins encoded by the dengue genome.
B. CTLs FOLLOWIG NATUR SECONDARY INECTION WITH 
DENGUE
VIRUS
Most of the research on human cytotoxic T cell responses to dengue viruses has
been performed using Caucasian volunteers who received experimental live monovalent
dengue vaccines. These individuals had no known prior exposure to dengue viruses and
therefore they received the dengue vaccine as a 
primar inection. However, the
complications seen in dengue infection (DHF and DSS) are more common in patients
who have preexisting imunty to one serotye of virus durng infection with another
serotye (secondar infection) of virus. Activation of dengue virus-specific memory T
cells has been implicated in the pathogenesis of severe dengue infection (Kurane and
, .
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Enns, 1992). Analysis ofT cell responses in patients after natual secondar infections is
therefore important because it may provide insights into the mechansms of T cell
mediated imunopathology.
1. Imunodominance of nonstrctual proteins as CTL targets
In the study done in Chapter IV, memory CTL responses were detected against
dengue proteins in the PBMC of all four patients examined. This is the first report of
dengue-specific CTLs after natual secondar dengue infections. In our previous work on
CD4+ CTLs and the work done in Chapter III on CD8+ CTLs, we have shown that
nonstrctual proteins, in paricular NS3 , are a predominant target for CTLs (Livingston
et aI. , 1995 , Mathew, et aI. , 1996, Zeng, et aI. , 1996). In the present study, we also found
that, all 4 donors had CTL responses to NS3 , and two donors had CTLs that recognzed
the nonstrctual proteins NS1.2a (Table VI-3). Therefore NS3 is an imunodominant
protein recognzed by CTLs even in patients who have had a natual infection with
dengue virus.
2. Serotye-specificity of CTL responses
Our earlier work, analyzing CTL responses to primar dengue infection in PBMC
of vaccine recipients, generated several T cell lines ftom dengue imune donors that had
varng specificities (Kurane, et aI. , 1991b, Mathew, et aI. , 1996). These tyically include
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serotye-specific, dengue-subcomplex-specific and virs serotye-crossreactive T cell
clones. We speculated that the serotye crossreactive memory T cells generated durng
the primar infection would be reactivated in a secondar infection and contrbute to the
immunopathology ofDHF , which is observed much more ftequently in secondar
infections. This hypothesis predicted that most of the T cells isolated following a
secondar infection would be serotye-crossreactive.
In the study done in Chapter IV we examined CTL responses after secondar
infection in 4 Thai patients. All the NS 1.2a specific CTL lines generated from patient
KPP94-037 and the NS3 specific CTLs from patient KPP94-024 were crossreactive with
the other serotyes of dengue virus. The bulk cultue CTLs from patient CHD94-020
who was infected with dengue-4 virus, were also crossreactive with dengue 2 and dengue
3 NS3 . We have not yet analyzed the CTL responses to primar dengue virus infection in
Thai children; therefore, we canot conclusively define the relationship between primar
and secondar dengue infections. However, these results suggest that the CTL responses
in secondar infections are predominantly due to reactivation of memory cross-reactive
CTL from the priar infections, consistent with our hypothesis. The CTL responses of
Thai patients to natual secondar dengue infection are directed against nonstrctual
proteins and are mainly serotye-crossreactive.
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3. HLA restrction of dengue-specific CTLs from Thai children
Imune responsiveness is affected by the major histocompatibility complex and
the pathogenesis of some diseases has been associated with specific HLA alleles. In areas
where DHF is endemic, only a small percentage of individuals exhbit severe disease.
This suggests that host genetic factors may playa role in susceptibility to severe disease.
One study found a positive association between HLA-A2 and B blan and the
development ofDSS and a negative relationship for HLA-B13 (Chiewslip, et aI. , 1981).
Since it is lrown that there is diversity in both HLA and non-HLA gene loci
between South East Asians and Caucasians (Chandanayingyong, et aI. , 1997), it was
important to analyze the recogntion of dengue viral proteins by T cells in the context of
tyical HLA molecules in Thai patients. We previously isolated NS3 specific CD4+ and
CD8+ CTL clones from Caucasian volunteers which were restrcted by the HLA alleles
B35 (Livingston, et aI. , 1995), DR15 (Kurane, et aI. , 1991b)and DPw2 (Kurane, et aI.
1993) (Figue VI-2).
The NS 1.2a -specific CTLs from patient KPP94-037 in the present study were
B57 restrcted and DR7 restrcted; the NS3 specific CTLs from patient KPP94-024 were
B7 restrcted and the NS3 specific CTLs from patient CHD94-020 were Al1. 1 restrcted.
These results indicate that despite differences in HLA alleles between Thais and
Caucasians , peptides from dengue nonstructual proteins are also predominantly
recognzed by T cells .from Thai children. These studies confirm our previous results of
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the domiance of nonstrctual proteins as CTL targets in Caucasian dengue vaccine
recipients.
4. Epitope analysis ofT cell lines ftom patient KPP94-024
All of the T cell lines isolated from patient KPP94-024 recognized autologous
targets pulsed with a.a 221-235 of the NS3 protein. This 15mer, which is lysed by all the
B7 restrcted CD8+ CTLs from ths patient, contains a proline at position 223 . These
results are consistent with reports that antigenic peptides bearng a proline at position 2
and aromatic or hydrophobic residues at their C-terminus bind to HLA-B7 and related
class I alleles sharng the B7-1ike superte (Sidney, et aI. , 1996).
There are a wide varety of factors that may contribute to the development ofDHF
and DSS. Vaccine strategists therefore need to carefully weigh the options as they have to
develop a vaccine that stimulates protective responses without increasing the risk of
immunopathological consequences. Considerable work stil needs to be done to elucidate
the roles ofCD4 and CD8 T cells in viral clearance and pathology. These studies
identifying CTL responses in volunteers who have received candidate live dengue virus
vaccines and in children following natual dengue infection wil guide scientists in the
development of a protective and effective vaccine to prevent dengue virus infections.
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C. ATTEMPTS TO ISOLATE DENGUE-SPECIFIC CTLs DURG ACUTE
INECTION
We were interested in characterizing dengue-specific T cells in patients with acute
DF or DHF. We hypothesized that these T cells would be activated in vivo, play an
important role in the pathogenesis ofDHF, and also contrbute to the recovery from
infection. We wanted to isolate dengue-specific CTLs in samples obtained when the
patients were sick and admitted into the hospital, and determine their protein recognition
serotye specificity and HLA restrction. Our eventual ai was to follow these in vivo
activated T cells durg the acute infection and determine if a subpopulation of acute cells
would become memory cells using T cell receptor gene sequences as markers for analysis
of 6 or 12 month follow-up bleeds from the same patients.
As shown in Table VI- , we attempted several technques to isolate and
characterize acute phase T cells specific for dengue but were not successful. Since we
speculated that some dengue-specific T cells would be activated in vivo durg acute
illness and have upregulated their IL-2 receptors, as one approach we initially cultued
the PBMC with IL-2 to preferentially select for these activated cells. Both bulk cultures
and T cell lines grew well in vitro when cells were cultued in IL- , but neither bulk
cultues or lines lysed dengue-infected target cells. Whenever IL-2 was not initially added
to the cultues , cell growth was very poor and the cultues could not be maintained..
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These observations prompted us to examine the acute PBMC to see if they proliferated in
vitro to varous stimuli
D. IMAID CELL MEDIATED RESPONSES DURG ACUTE DENGUE
INECTION
The results in Chapter V demonstrate decreased in vitro proliferative responses of
PBMC to mitogens and to several antigens durng acute dengue infection. All the
responses ofPBMC from children with acute dengue inection were compared to the
responses ofPBMC obtained from the same patients 6-24 months after the infection. In
all patients studied (Table ll-4), in vitro proliferative responses were abrogated durng
acute dengue infection. Decreased proliferative responses to PHA and anti-CD3 were
seen in patients with DF and in those with DHF, in patients with primar infections and
those with secondar infections, and in those infected with any of the four dengue
serotyes. Therefore, neither the severity of illness nor the serotye of virus that the
person had been infected with appeared to influence the extent of unesponsiveness of
PBMC to the different stimuli tested.
This study is the first report of impaired cell mediated responses of the PBMC of
patients with acute dengue infection. Our results are consistent with observations in
several other viral infections, such as measles, EBV and CMV (Carey and Hirsch, 1981
Hirsch, et aI. , 1984) . atients ' PBMC samples obtained durng acute illness from these
\,.'-
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varous other viral infections have shown similar unesponsiveness to stimulation with
PHA, ConA and specific antigen.
A varety of mechansms for virs-induced immunosuppression have been
suggested includig, 1) virs killing of inected lymphocytes, 2) production of suppressor
T cells , 3) a shift towards a Th2 response by the release ofTh2 cytokines such as IL-
and a lack of a potent Thl proinflamatory cytokine such as IL- , 4) induction of
apoptosis of T cells upon antigenic challenge in vitro, 5) impairment of monocytes by
release of TNF and PGE2 , and, 6) impairment of dendrtic cells leading to decreased IL-
12 production (Fugier-Vivier, et aI. , 1997, Kar, et aI. , 1996 , Nokta, et aI. , 1996 , Rouse
and Horohov, 1986). One or more of these factors could playa role in contrbuting to the
:uunosuppreSSlOn seen.
1. Role ofT cells and AP s in mediatin unes onsiveness ofPBMC
Changes in both T cells and antigen presenting cells have been implicated in
mediating the suppression of in vitro proliferation. T lymphocytes from patients with 
and EBV have been shown to undergo apoptosis in vitro upon stimulation of the TcR
(Lauener, et aI. , 1995 , Uehara, et aI. , 1992). In acute EBV infection, both CD4+ and
CD8+ T cells were shown to die upon cultue, and the dyig cells were restrcted to the
activated (CD45RO+) population (Tamar, et al. , 1993). Death of the T cells could be
prevented by the additiql:;l of recombinant IL-2. Similarly, in acute LCMV infection virus-
128
induced immunodeficiency was shown to be predominantly a result of T cells undergoing
apoptosis (Razvi and Welsh, 1993). However, in ths situation IL-2 appears to sensitize
and accelerate apoptosis of memory T cells specific for nonviral antigens upon
subsequent stimulation. These studies did not examne whether the accessory cell
population contrbuted to the observed immunosuppression.
Since the background thymidine incorporation was lower in acute PBMC in all
cases in our study, it could imply that the acute PBMC cultued in medium alone were
more susceptible to apoptosis than normal PBMC. However, the addition of gama-
iradiated feeder cells, IL- , IL-7 or antiCD28 antibodies could restore proliferation of the
acute T cells, indicating that these cells could be rescued. Though we have not directly
tested to see if acute T cells in dengue inection undergo apoptosis upon in vitro
stimulation, our results suggest that the T cells can proliferate if provided with an
adequate stimulus.
To test if one cell tye predominantly accounts for the unesponsiveness of the
PBMC, we separated T and non- T cells using magnetic beads and performed mixing
experiments. The results demonstrate that the accessory cells in the acute PBMC sample
are incapable of providing the signals to help the T cells proliferate, because both acute
and control T cells are incapable of responding to PHA in the presence of irradiated acute
non-T tells. However, the T cells in the acute PBMC samples are capable of responding
to the appropriate signals, because proliferation increased substantially when irradiated
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non- T cells from a control donor were added to the culture.
The defect in the accessory cell population in the acute PBMC is not exclusively
an antigen processing defect because it was also observed with mitogens. The accessory
cells in the acute PBMC sample either lack an adequate stimulus or are providing a
negative signal that makes them incapable oftriggering the activation ofT cells from
samples of acute or control PBMC. Incubation of acute PBMC with autologous immune
PBMC did not decrease the proliferation of the immune PBMC (data not shown);
therefore we believe that during acute dengue infection the accessory cells in the PBMC
are unable to provide the necessar stimulus to activate the T cells. Although we canot
entirely exclude the possibility that a small proportion of the acute T cells are triggered
into activation-induced cell death, our results indicate that the primar defect is in the
antigen presenting cell population. Cell surface molecules on the accessory cells in the
irradiated control non- T population may provide the necessary signals needed to trigger
the activation of acute T cells. Accessory cells are necessary to help polyclonal activation
ofT cells with PHA by crosslinking the TcR and by providing second signals or soluble
factors to induce activation.
Both cell contact dependent and soluble factors released from APC's have been
shown to mediate unresponsiveness of T cells. Inhibition of proliferation of antigen
specific T cells by human rhinoviruses was shown to be dependent on virion binding to
ICAM- l on monocytes (Gem, et aI. , 1996). Supernatants from CMV- infected monocyte
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cultures were shown to inhbit mitogenic T cell proliferative responses through the TN-
dependent release of arachidonic acid and prostaglandin E2 (Nokta, et aI. , 1996).
Recently, suppression of antigen specific proliferation by measles virus infection was
shown to be mediated by a soluble factor which the authors speculate is an undescribed
cytokine (Fujinami , et aI. , 1998 , Sun, et aI. , 1998). However, Kar et al have shown that
crosslinking of the measles virus receptor CD46 inhibited monocyte production ofIL-
, '
which is known to be important for the generation of cell mediated responses (Kar, et
aI. , 1996). Salonen et al suggested that early inhibition of proliferation is due to the
release ofIFN-a from monocytes and subsequent cell death of the mitogen stimulated
cells (Salonen, et aI. , 1989). All of these studies analyzed the unresponsiveness of T cells
by infecting monocytes or PBMC with the respective viruses in vitro , and then examining
the effect of these infected monocytes or PBMC on T cell proliferation. How this relates
to the observed suppression seen during or following in vivo infection with any of these
viruses is still in question. Analysis of patients ' PBMC samples obtained during an acute
viral illness has not yet been done in as great detail as the described in vitro studies in
those systems. Demonstration of altered plasma levels of IL- , TNF , PGE2 in patients
with acute measles or CMV compared to healthy or immune controls would complement
the in vitro studies and provide more direct evidence that these cytokines are important
mediators of immune suppression in infected individuals.
Our rationale for using the transwell system was to see if gamma irradiated
autologous or allogeneit PBMC would restore proliferation of the T cells in the aCMte
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samples ofPBMC by the release of soluble factors. If this was the case, the acute cells
should have been able to proliferate when separated by a membrane from the irradiated
allogeneic PBMC. Since the patients ' acute cells had signficantly lower proliferation
when separated by the polycarbonate membrane, our results suggest that the initial
trggerig between acute PBMC and gama-irradiated control PBMC requires cell-cell
contact. It is possible that soluble growt factors are produced by the acute T cells as 
result of this initial cell contact dependent stimulation, which can then act to restore
proliferation. This may explain why cytokines such as IL-2 or IL- , which are produced
downstream of signaling events, are able to increase the proliferative responses in the
acute cells. The inability of the PBMC ftom one patient to respond to even high doses of
IL-2 may reflect a more severe state of immunosuppression and this patient did exhibit
more severe disease manfestations (DHF grade 2). Since we had a limited number of
PBMC from this patient it was not possible to fuher characterize this defect.
The absolute monocyte and absolute neutrophil counts are transiently decreased in
patients with dengue illness compared to children with other febrile illnesses
(Kalayanarooj, et aI. , 1997). The in vitro T cell responses we have observed are
signficantly depressed for at least two weeks after the appearance of fever in these
patients. The reduction in monocytes could result in fewer total co stimulatory ligands
such as B7- 1 and B7- , and adhesion molecules available to activate the T cells in the
acute samples. The results suggest that one ofthe reasons for the decrease in cell-
, ..
l1-
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mediated responses in children with acute dengue infection may be a decrease in the
expression of co stimulatory molecules on the antigen presenting cells as a result of the
decreased number of monocytes seen durng acute dengue infection.
Depletion ofmonocytes from PBMC of control donors decreases the anti-CD3
response but not the PHA response, whereas depletion ofB cells does not affect the
proliferation ofPBMC (data not shown). This suggests that decreases in the monocyte
counts in the acute PBMC of the dengue patients do not solely account for the marked in
vitro suppression observed. Infection of monocytes, which are the main target of dengue
infection, may cause a series of abnormalities and result in the inability of T cells to
respond to most stimuli in vitro.
Plasma levels ofIL- lO are increased in patients with DF and DHF (S. Green et al
manuscript submitted). IL- I0 is a cytokine with known imunosuppressive properties
(Schols and De Clercq, 1996 , Taga and Tosato , 1992). It downegulates monocyte
production of several co stimulatory molecules, including B7 - 1 and B7 - , which are
important for the activation ofT cells. Groux et al showed that IL- I0 suppresses
proliferation and induces alloantigen-specific unesponsiveness of human CD8+ T cells
(Groux, et aI. , 1998). This effect was due to the downegulation of co stimulatory
molecules on the monocytes. It is possible t at increased levels ofIL- 10 in dengue
patients in vivo alters the expression of co stimulatory molecules on monocytes, making
them incapable of activating T cells in the presence of mitogens.
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Addition of anti-CD28 antibodies did not induce T cell proliferation of the acute
samples ofPBMC obtained on study days 2 or 3 , when patients are tyically viremic and
have their most severe symptoms of disease. When the patients were recovering from
their acute illness and the monocyte levels were slowly retung back to normal levels
the anti-CD28 antibodies improved proliferation of acute PBMC samples (Figure IV -4).
It is possible that the addition of co stimulatory molecules at the earlier stage of illness
canot trgger suffcient production ofIL-2 for T cell proliferation and therefore had no
effect on the proliferation in the acute PBMC samples. Previous studies of patients with
measles and CMV have not examined the effect of antiCD28 antibodies on acute T cell
proliferation. It is interesting to speculate that in acute dengue infection the lower density
of surface B7 molecules might preferentially trgger the high affity receptor CTLA-
(instead of the low affnity receptor CD28), which has been shown to provide inhbitory
signals and prevent proliferation. Ths would provide one explanation why in vitro
proliferation is abrogated in acute dengue infection. Other interactions between T cells
and APC' , like CD40/CD40L and LFA-3/ICAM- , may also be important to generate a
good proliferative response.
The receptors for several cytokines, e.g. IL- , IL- , IL- , IL- 13 and IL- , have
common motifs and share the Yc chain, resulting in cytokine redundancy (Lin, et aI.
1995); IL- , IL- , IL- , IL-9 and IL- 15 can all act as T cell growt factors and therefore
might be able to help restore proliferation of the unesponsive acute T cells. Purfied CD4
T cells that had been rgized by ligation of gp120 with CD4 were unable to respond to
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anti TcR antibodies (Selliah and Finel, 1998). Addition of IL- , IL-4 or IL-7 restored
proliferation of these cells whereas cytokines that bound to receptors without the 
Yc chain
(IL-6 and IL- 12) could not. The cytokines that share a common Yc activate the Jak family
tyosine kinases Jakl and Jak3. IL-2 and IL-7 induce different Stat proteins (Stat 3 and
Stat 5) compared to IL-4 and IL-13 in preactivated peripheral blood lymphocytes even
though they all activate the same Jak kinases (Lin
, et aI. , 1995). Our data indicate that IL-
2 or IL- , but not IL- , can restore proliferation ofPBMC obtained durng acute dengue
infection. Therefore, although these cytokies share common receptor motifs, there
appears to be selectivity in the ability of the acute cells to respond to them.
The analysis of the unesponsiveness ofPBMC to in vitro stimuli durng acute
dengue inection in the present study poses several questions that might be addressed in
the futue. It wil be interesting to examine which Stat proteins are induced in the PBMC
following stimulation with CD3 and IL-2. We would like to see whether antiapoptotic
genes, such as bcl . are induced in the acute PBMC and if signaling through the JakStat
pathway is altered in these cells. We would also like to determne which population of
antigen presenting cells is responsible for the alterations in T cell proliferation.
The suppression of in vitro proliferation seen in measles infection is associated
with in vivo imune defects. The tuberculin skin test response is depressed durng acute
measles from prior to the appearance of the rash til 7-20 days afterwards (Tamashiro, et
aI. , 1987). Children with measles are more susceptible to secondar infections, which
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contrbutes to the nearly one milion measles-related deaths worldwide each year (Borrow
and Oldstone, 1995). There are no published studies on the susceptibility to secondar
infections after acute dengue virus infections or on DTH responses in patients with acute
dengue. Unlike measles, dengue virus infections do not involve mucosal surfaces.
However, studies of the in vivo implications of these in vitro observations may be
waranted. It would be of interest to perform in vivo testing of delayed tye
hypersensitivity of dengue patients to an antigen such as PPD.
There are theories concerning the mechansm of measles virus-induced
immunosuppression (Figue VI-3) (Borrow and Oldstone, 1995 , Oldstone, 1996). One
idea put fort is that measles virus infection selectively interferes with the cells ' ability to
make product(s) necessar for their differentiated fuction i.e. their roles in immune
responses (A), because there is no interference with protein synthesis and no direct cell
lysis of measles infected lymphocytes. A second hypothetical mechansm by which
immunosuppression may occur is via cell-cell interactions mediated by measles virus
glycoproteins. The interaction of a lymphocyte (L Y) with the measles virus
hemagglutinin (H) and fusion (F) proteins on infected cells delivers a transmembrane
signal (arows) that arests the proliferation of the responding cell. Adhesion molecules
may facilitate suppression by enhancing cell-cell interactions. This suppressive activity
can occur only between infected cells (B), or an unected lymphocyte could be affected
by an infected APC (C). The infected APC could be a monocyte/macrophage, dendrtic
cell or B cell as indicated by several reports. This second hypothesis is attactive because
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Figure VI-3. Hypothetical mechanisms by which measles virus-induced suppression
occur (From Borrow et al Cur.Top.Microbiol.Imunol. 191:85-100)
. Virus hemagglutinin protein H, Is virus fusion F protein cell adhesion molecules
APC = antigen presenting cell, L Y = lymphocyte 9 = negative signal
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a relatively small number of cells infected by measles virus may have a far-reaching
effect on the immune response mounted by a large population ofunnfected cells.
In light of the data that exist in several other viral systems of acute viral
immunosuppression, our results indicate that generation of immunosuppressive T cells or
suppressor macrophages is not liely to be the mechansm by which T cell responses are
abrogated in acute dengue infection. If this were the case, we would have expected
reduced proliferative T cell responses of convalescent healthy PBMC when they were
incubated with acute PBMC from patients with dengue infection. Instead, our data point
to inadequate stimulation ofthe T cells by antigen presenting cells. This defect is global
because it affects T cell responses to both specific antigens and mitogens. It is not
priarly an antigen processsing defect, since even responses to PHA were reduced in
patients ' PBMC samples. We have not established if a paricular subset of accessory cells
is responsible for ths immunological unesponsiveness.
We hypothesize that the increased levels ofIL- 10 in patients with DF and DHF
alter APC' s by decreasing expression of co stimulatory molecules and other adhesion
molecules on their surface (Figure VI-4). Acute APe's therefore canot provide adequate
secondar stimulation to the T cells in order to induce proliferation. Although we have
not specifically examed T cells in acute dengue infection to see if they are undergoing
apoptosis, we believe that the majority ofT cells are fuctional because when they are
provided with the right signals (from gama-irradiated autologous convalescent or
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allogeneic PBMC , anti-CD28 antibodies, IL-2 and IL-7) they wil proliferate. The results
suggest that there is a primar defect in the APC population in acute dengue infections.
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Figure VI-4 MODEL: Acute APC' s in dengue infection are unable to provide
adequate stimulus to trigger activation of T cells
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The results presented in this thesis examine T cell responses durng acute dengue illness
and CD8+ memory CTL responses following dengue virus infection. The major
conclusions of ths thesis are:
1. CD8+ CTL responses can be detected in most volunteers who have received a
monovalent dengue vaccine. Nonstrctual proteins, in paricular NS3 , are dominant
targets for recogntion by CTLs. There is no immunodominant epitope on NS3.
2. Dengue-specific memory CTL responses are detected in Thai children following
natual secondar dengue infection. Nonstrctual proteins are immunodominant
targets for CTLs, consistent with our data on healthy dengue vaccine recipients. The
majority of T cell lines established from these patients are crossreactive with the other
serotyes of dengue virus.
3. Durg acute dengue infection, in vitro T cell proliferative responses are abrogated.
These responses can be restored by the addition ofIL- , IL- , irradiated autologous
convalescent or allogeneic PBMC, and, in some cases , by anti-CD28 antibodies. The
primar defect appears to be in the antigen presenting cell population. This
suppression of acute PBMC observed in vitro may explain our inability to isolate
dengue-specific CTLs in the same samples.
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